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AN ECONOMIC ANALYSIS OF PATENT LAW'S
INEQUITABLE CONDUCT DOCTRINE
Thomas F. Cotter*
In recent years, patent law's inequitable conduct doctrine has attracted
considerable attention from judges, legislators, patent lawyers, and commentators.
This trend culminated most recently in Therasense, Inc. v. Becton, Dickinson &
Co., an en banc decision from the Federal Circuit that revised certain aspects of
the doctrine. Building on the work of other scholars, this Article proposes an
instrumental view of the doctrine as, ideally, a tool for inducing patent applicants
to disclose the optimal quantity of information relating to the patentability of their
inventions; it then presents a formal model of the applicant's choices in deciding
how much information to reveal. The model suggests, among other things, that
even after Therasense, the conditions that trigger a finding of inequitable conduct
are at best only a rough proxy for the conditions defining optimal disclosure. The
model also illuminates how, both pre- and post-Therasense, the doctrine poorly
defines many of the variables affecting a rational applicant's decisionmaking
process and thus potentially encourages risk-averse agents to overdisclose.
Although the model neither confirms nor refutes critics' claims that the doctrine
routinely induces overdisclosure and excessive administrative costs, the model
demonstrates how various reforms including but not limited to those adopted in
Therasense, can be expected to reduce these reputed consequences. The model
also suggests, however, that the need for some type of inequitable conduct doctrine
may be greater in a regime like the United States, which lacks an effective system
for post-grant oppositions. Conversely, if the United States adopted a post-grant
opposition system, the need for a robust inequitable conduct doctrine would
decline.
* Briggs and Morgan Professor of Law, University of Minnesota Law School.
I thank Nicholas Tymoczko and Sanjiv Laud for research assistance; and, for their
comments and criticism, Chris Cotropia, Dan Gifford, and Dan Schwarcz; participants in
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736 ARIZONA LAW REVIEW [VOL. 53:735
TABLE OF CONTENTS
IN TROD U CTION .............................................................................................. 736
I. D OCTRINAL C ONTOURS ............................................................................. 741
II. A FORMAL MODEL OF THE INEQUITABLE CONDUCT DOCTRINE ............... 752
A. A Socially Optimal Inequitable Conduct Doctrine ............................. 752
B. Modeling an Applicant's Incentive to Disclose ................................... 757
C. Modeling Materiality, Intent, and Balancing ....................................... 762
III. IMPLICATIONS OF THE PRECEDING ANALYSIS .......................................... 766
A. The Gap Between Theory and Practice ............................................... 767
B. Predicting the Effects of Various Proposed Reforms .......................... 770
1. Some Commonly Suggested Reforms ............................................. 770
2. The Effect of Risk Aversion ............................................................ 774
3. Som e Less Obvious Reform s .......................................................... 775
C O N CLU SION ................................................................................................. 778
INTRODUCTION
In patent litigation, the defense of inequitable conduct to a claim of patent
infringement authorizes a court to render an otherwise valid patent unenforceable
if the accused infringer can prove that, during the course of applying for
("prosecuting") the patent before the U.S. Patent and Trademark Office
("USPTO"), the inventor or her associates either intentionally submitted materially
false information relating to the invention at issue or intentionally failed to disclose
information that was material to the examination of the patent application.'
Although courts did not clearly recognize (and litigants rarely invoked) the
inequitable conduct doctrine until the middle to later part of the twentieth century,
the doctrine has emerged from obscurity over the past 30 years to become one of
the most frequently raised defenses-and most hotly debated topics-in
contemporary patent law. 2 The doctrine nevertheless often has been surprisingly
1. See infra Part I.
2. Estimates of how often the defense is asserted vary somewhat. See
Christopher A. Cotropia, Modernizing Patent Law's Inequitable Conduct Doctrine, 24
BERKELEY TECH. L.J. 723, 739 (2009) (stating that the defense is asserted in about 25% of
all patent cases filed); Christian E. Mammen, Controlling the "Plague": Reforming the
Doctrine of Inequitable Conduct, 24 BERKELEY TECH. L.J. 1329, 1358 tbl.2 (2009)
(presenting an empirical study concluding that the defense was raised in about 40% of all
patent cases filed since 2007); Benjamin Brown, Comment, Inequitable Conduct: A
Standard in Motion, 19 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. 593, 605-15 (2009)
(reporting that from 2000 to 2007 "courts addressed, on average, inequitable conduct in less
than 20% of all reported patent cases," but that "it is almost impossible to ascertain the
number of times inequitable conduct was pled"); Kevin Mack, Note, Reforming Inequitable
Conduct to Improve Patent Quality: Cleansing Unclean Hands, 21 BERKELEY TECH. L.J.
147, 155-56 & tbl.1 (2006) (reporting that "from 2000 to 2004 ... an inequitable conduct
adjudication appeared in 16% to 35% of all reported patent opinions," and that "it can be
inferred that the percent of patent cases in which a litigant ple[d] inequitable conduct is
substantially higher than these figures"). In its recent decision in Therasense, Inc. v. Becton,
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Dickinson & Co., the Federal Circuit noted that "[o]ne study estimated that eighty percent
of patent infringement cases included allegations of inequitable conduct." Nos. 2008-1511,
-1512, -1513, -1514, -1595, 2011 WL 2028255, at *8 (Fed. Cir. May 25, 2011) (en banc).
The position paper referenced by the court for this proposition, however, is over 20 years
old and cites no supporting data for its estimate. Ad Hoc Comm. on Rule 56 and Inequitable
Conduct, Am. Intellectual Prop. Law Ass'n, The Doctrine of Inequitable Conduct and the
Duty of Candor in Patent Procurement: Its Current Adverse Impact on the Operation of the
United States Patent System, 16 AIPLA Q.J. 74, 75 (1988). Similarly, some Federal Circuit
judges have referred to the "habit of charging inequitable conduct in almost every major
patent case" as "an absolute plague," see Larson Mfg. Co. v. Aluminart Prods. Ltd., 559
F.3d 1317, 1342 (Fed. Cir. 2009) (Linn, J., concurring) (quoting Kingsdown Med.
Consultants, Ltd. v. Hollister Inc., 863 F.2d 867, 876 n.15 (Fed. Cir. 1988)), a charge that is
repeated in Therasense, see 2011 WL 2028255, at *9, but the reference to the doctrine being
raised in "almost every major patent case" appears to be something of an overstatement, see
Mammen, supra, at 1331 (citations omitted); Brown, supra, at 626.
The following examples illustrate the ongoing debate involving the doctrine: S. REP.
No. 110-259, at 31-33 (2008) (discussing proposed changes to the doctrine, including
permitting courts to consider sanctions other than unenforceability of the patent in its
entirety); id at 59-62 (providing additional views of Senators Specter and Hatch on the
inequitable conduct doctrine, who argue that courts need more guidance concerning when to
impose "more severe or less severe penalties"); FED. TRADE COMM'N, To PROMOTE
INNOVATION: THE PROPER BALANCE OF COMPETITION AND PATENT LAW AND POLICY ch. 5, at
11-13 (2003), available at http://www.ftc.gov/os/2003/10/innovationrpt.pdf (recommending
expanded use of relevance statements); NAT'L RESEARCH COUNCIL, A PATENT SYSTEM FOR
THE 21ST CENTURY 121-23 (Stephen A. Merrill et al. eds., 2004) (proposing abolition of the
doctrine, or in the alternative various reforms); SECTION OF INTELLECTUAL PROP. LAW, AM.
BAR ASS'N, RECOMMENDATION 107B (2009), available at http://
www.abanow.org/wordpress/wp-content/themes/ABANow/wp-content/uploads/resolution-
pdfs/107B.pdf (recommending that the doctrine be limited to situations in which fraud
results in the granting of one or more invalid claims); Robert A. Armitage, Inequitable
Conduct and Post-Grant Review: Why the Imperative to Eliminate the "Inequitable
Conduct" Defense? What Relates Eliminating the Defense to Expanding Post-Grant
Review?, AM. INTELL. PROP. L. Ass'N, Jan. 2009, at 1-5 (arguing in favor of abolition);
Cotropia, supra, at 737-46, 773-83 (reviewing critiques of current doctrine and proposing
reforms); Lisa A. Dolak, Inequitable Conduct: A Flawed Doctrine Worth Saving, in 4th
ANNUAL PATENT LAW INSTITUTE, at 877, 879, 881-92 (PLI Patents, Copyrights, Trademarks
& Literary Prop., Course Handbook Series No. 997, 2010), available at
http://ssm.com/abstract=1588916 (reviewing critiques of current doctrine and proposing
reforms); Robin Feldman, The Role of the Subconscious in Intellectual Property Law, 2
HASTINGS SCI. & TECH. L.J. 1, 14-23 (2010) (arguing that current doctrine "requires
inventors to act against their own interests and in a manner that contradicts their instincts,
and then charges them with immoral behavior for an inability to consciously override those
instincts"); Senator Orrin G. Hatch, Keynote Address at the National Press Club in
Washington, D.C. (Mar. 18, 2009), in 78 GEO. WASH. L. REV. 513, 517 (2010) (arguing for
a narrower definition of materiality); Mammen, supra, at 1390-94 (presenting reform
proposals); Kate McElhone, Inequitable Conduct: Shifting Standards for Patent Applicants,
Prosecutors, and Litigators, 17 TEX. INTELL. PROP. L.J. 385, 405-12 (2009) (proposing
various reforms and discussing other proposals); David McGowan, Inequitable Conduct, 43
LOY. L.A. L. REV. 945 (2010) (arguing for a reformed version of the doctrine); Lee
Petherbridge et al., The Federal Circuit and Inequitable Conduct: An Empirical Assessment,
84 S. CAL. L. REV. (forthcoming 2011) (presenting an empirical study of the courts'
application of the doctrine and concluding that the doctrine rarely succeeds in practice);
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uncertain both in its application and efficacy in promoting the goals of the patent
system.
Conventionally, the law of inequitable conduct (like its cousin, patent
misuse) can be viewed as an outgrowth of the equitable doctrine of unclean
hands-in the present context, as a means of preventing patent owners from
profiting through fraud on the USPTO.3 Courts have expanded the doctrine's reach
so that in its present incarnation, inequitable conduct encompasses not only
misrepresentations and omissions amounting to outright fraud but also to an
amorphous category of somewhat lesser sins. The Federal Circuit has made clear,
for example, that conduct need not rise to the level of fraud that would sustain a
Walker Process antitrust claim in order to be characterized as inequitable conduct.4
Nevertheless, defining exactly what inequitable conduct is has sometimes proven
elusive; as discussed below, case law has often defined the doctrine's key elements
of "intent" and "materiality" in ways that seem both imprecise and inconsistent.5
For practical purposes, the significance of the doctrine resides in the fact that a
finding of inequitable conduct results in the unenforceability of all of the claims of
the patent at issue and sometimes even of related patents.6 Alarmed at these
potential consequences, critics charge that the doctrine has become a death
sentence for minor offenses,7 while defenders counter that the doctrine deters
Randall R. Rader, Always at the Margin: Inequitable Conduct in Flux, 59 AM. U. L. REv.
777, 785 (2010) (arguing in favor of clearer standards); David 0. Taylor, Patent Fraud, 83
TEMP. L. REv. 49, 72-73, 77-98 (2010) (arguing that inequitable conduct should be limited
to the fraudulent procurement of patents, and that other penalties should be imposed for
lesser misconduct, and proposing other possible reforms); Melissa Feeney Wasserman,
Limiting the Inequitable Conduct Defense, 13 VA. J.L. & TECH. 7, 16-22 (2008) (arguing
for limiting the doctrine to common law fraud and for a range of penalties); Brown, supra,
at 616-20 (reviewing testimony presented at Patent Reform Act hearings); Mack, supra, at
166-75 (proposing various reforms); Nicole M. Murphy, Note, Inequitable-Conduct
Doctrine Reform: Is the Death Penalty for Patents Still Appropriate?, 93 MINN. L. REV.
2274, 2274-75, 2296-2302 (2009) (reviewing critiques of current doctrine and proposing
guidelines for a range of sanctions); Katherine Nolan-Stevaux, Note, Inequitable Conduct
Claims in the 21st Century: Combating the Plague, 20 BERKELEY TECH. L.J. 147, 164-72
(2005) (discussing and proposing various reforms); The Patent Reform Act Will Hurt, Not
Help, the U.S. Patent System, PATENT OFFICE PROF'L Ass'N (Sept. 2007),
http://www.popa.org/pdf/misc/reform-popa-04sep2007.pdf (arguing that proposed Patent
Reform Act changes to the doctrine would reduce applicant candor and render the doctrine
moot).
3. See Cotropia, supra note 2, at 728 (noting the conventional understanding of
inequitable conduct as a doctrine rooted in equity rather than in utilitarian considerations).
4. See Dippin' Dots, Inc. v. Mosey, 476 F.3d 1337, 1346-48 (Fed. Cir. 2007).
A Walker Process claim is an antitrust claim premised on the theory that the antitrust
defendant's enforcement of a fraudulently procured patent constitutes an act of
monopolization or attempted monopolization in violation of Sherman Act § 2. See Walker
Process Equip., Inc. v. Food Mach. & Chem. Corp., 382 U.S. 172, 177 (1965);
Nobelpharma AB v. Implant Innovations, Inc., 141 F.3d 1059, 1068 (Fed. Cir. 1998).
5. See infra Part I.
6. See id.
7. See Murphy, supra note 2, at 2274 (quoting Robert Armitage as likening the
penalty to "imposing the death penalty for relatively minor acts of misconduct"); see also
[VOL. 53:735738
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misconduct and thus contributes to the integrity of patent prosecution and
enforcement.8 And, although the Federal Circuit's recent en banc decision in
Therasense, Inc. v. Becton, Dickinson & Co.9 has recast the doctrine in ways that
likely will pacify some of the critics, the question still remains whether Therasense
succeeds in stemming further reforms or doctrinal adjustments. Congress has long
considered changes to the inequitable conduct doctrine as part of a comprehensive
system of patent reform,' 0 and, as of this writing, a certiorari petition in
Therasense seems likely."
Aventis Pharma S.A. v. Amphastar Pharm., Inc., 525 F.3d 1334, 1349 (Fed. Cir. 2008)
(Rader, J., dissenting) (referring to the "'atomic bomb' remedy of unenforceability").
8. See Dolak, supra note 2, at 881-86 (advocating reforms but ultimately
arguing in favor of retaining the doctrine because "inequitable conduct happens!"); Brown,
supra note 2, at 616-17 (reviewing congressional testimony in favor of retaining the
doctrine).
9. Nos. 2008-1511, -1512, -1513, -1514, -1595, 2011 WL 2028255 (Fed. Cir.
May 25, 2011) (en banc). The conduct at issue in Therasense consisted of representations
made to the USPTO by Abbott Laboratories' patent attorney and an Abbott executive
during the course of prosecuting what came to be the patent in suit-the '551 Patent. Id. at
*l1-2. Specifically, these individuals had represented that a person of skill in the relevant art
would have understood the phrase "optionally, but preferably" as used in a prior art patent
(the '382 Patent) to mean "necessarily." Id. On the basis of these representations, the
examiner allowed the '551 Patent. Id. at *2-3. It later came to light, however, that Abbott's
European patent counsel had made conflicting representations about the meaning of the
same claim term in an earlier proceeding before the European Patent Office involving the
European counterpart of the '382 Patent. See id. The legal issues surrounding application of
the inequitable conduct doctrine are discussed in Part I below.
10. The most recent actions in Congress were the approvals by the Senate of the
Patent Reform Act of 2011 and by the House Judiciary Committee of the American Invents
Act of 2011. Using identical language, both bills would modify the inequitable conduct
doctrine by allowing patent owners to request supplemental examinations "to consider,
reconsider, or correct information believed to be relevant to the patent" and providing that
"a patent shall not be held unenforceable on the basis of conduct relating to information that
had not been considered, was inadequately considered, or was incorrect in a prior
examination of the patent if the information was considered, reconsidered, or corrected
during a supplemental examination" concluded before the date on which the patentee files
suit for infringement. See S. 23, 112th Cong., § 10(a) (2011), available at
http://www.govtrack.us/congress/billtext.xpd?bill=s 112-23; HR 1249, 112th Cong., § 11 (a)
(2011), available at http://www.govtrack.us/congress/bill.xpd?bill=hl12-1249. Some
previous patent reform bills introduced in recent years would have reformed the doctrine in
other ways. See Patent Reform Act of 2009, S. 610, 111 th Cong., § 11 (2009), available at
http://www.govtrack.us/congress/billtext.xpd?bill=slll-610 (providing for administrative
proceedings and civil sanctions for misconduct before the USPTO, and otherwise stating
that "a patent shall not be held invalid or unenforceable on the basis of misconduct before
the Office"); Patent Reform Act of 2007, S. 1145, 110th Cong., § 12 (2008) (codifying the
reasonable examiner standard, among other things, and enabling courts to hold the entire
patent unenforceable; only some claims unenforceable; or to allow the patentee to recover
reasonable royalties only); Patent Reform Act of 2007, HR 1908, 110th Cong., § 12(b)
(2007) (codifying a materiality standard similar to the 1992 version of Rule 56 to allow
courts to consider a range of penalties); Patent Reform Act of 2006, S. 3818, 109th Cong., §
5(c) (2006) (providing that a court may not hold a patent unenforceable by reason of
inequitable conduct unless one or more claims are invalid; and that a defendant may not
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Some recent scholarship has begun to cast the inequitable conduct
doctrine in a more instrumental vein by focusing on the doctrine as, ideally, a tool
for encouraging patent applicants to engage in the optimal disclosure of
information relevant to their applications. 12 This Article builds upon this body of
work by modeling the variables a rational applicant would consider in deciding
how much information to reveal to the USPTO. The model suggests, among other
things, that the conditions that trigger a finding of inequitable conduct, both in the
doctrine's current and previous versions-as well as in various proposed
reformulations-are at best only a rough proxy for the conditions that define the
optimal disclosure of information relating to patentability. The model also
illuminates how poorly the doctrine has traditionally defined many of the factors
affecting a rational applicant's decisionmaking process and has potentially
encouraged risk-averse agents to overdisclose. Put another way, the model is
intended primarily to clarify what various factors the courts have identified as
relevant to the analysis might mean, how these factors relate to one another, and
how, depending on their meanings and interrelationships, they would be expected
to affect the behavior of both risk-neutral and, subsequently, risk-averse patent
applicants and their agents. Thus, although the model neither confirms nor refutes
critics' claims that the doctrine has routinely induced overdisclosure and excessive
plead the defense until there has been a judgment that the patent is "not invalid in whole and
has been infringed"); Patent Reform Act of 2005, HR 2795, 109th Cong., § 5 (2005)
(providing that a court must refer possible misconduct to the USPTO for investigation, but
only if one or more claims have been held invalid; and that it may declare a patent
unenforceable only if the USPTO concludes that inequitable conduct occurred).
11. See Kevin Noonan, Therasense, Inc. v. Becton, Dickinson & Co. (Fed. Cir.
2011) (en banc): Judge O'Malley's Opinion, PAT. DoCs: BIOTECH & PHARMA PAT. L. &
NEWS BLOG (May 30, 2011), http://www.patentdocs.org/2011/05/therasense-inc-v-becton-
dickinson-co-fed-cir-2011-en-banc-judge-omalleys-opinion.html; Harold C. Wegner, A
Post-Therasense Rule 56 Duty of Disclosure, IP FRONTLINE (May 30, 2011),
http://www.ipfrontline.com/depts/article.aspx?id=25337&deptid=7.
12. See Cotropia, supra note 2, at 746-62 (characterizing the doctrine as a tool
for attaining optimal patent quality); Clarisa Long, Patent Signals, 69 U. CHI. L. REv. 625,
668-71 (2002) ("By imposing higher costs on patentees who would attempt to take
advantage of high observer verification costs by making false statements in the patent,
penalties for inequitable conduct make it more costly for dishonest firms to mimic the
behavior of honest firms."); McGowan, supra note 2, at 974 (arguing that the doctrine
should reflect "the instrumental concern that examiners have the information they need to
decide whether an application satisfies the statutory criteria"); Taylor, supra note 2, at 63-
64 (discussing the costs of overdisclosure). The goals of attaining optimal patent quality, or
of preserving a patent's function as a signal of firm value, can be subsumed within the
broader utilitarian concept of optimal disclosure. As discussed in Part II of this Article, the
concept of optimal disclosure assumes that the patent applicant's disclosure of relevant
information, properly defined, promotes social welfare when (1) the applicant enjoys a cost
advantage over the examiner in discovering and disclosing the information, and (2) the
social benefits of additional disclosure outweigh the social costs of information overload.
When these conditions are not present, patent quality and signaling may suffer. See
Cotropia, supra note 2, at 770-73. This instrumental explanation for the doctrine attempts to
conform the doctrine to the utilitarian thrust of patent law generally, though it contrasts with
the more conventional understanding of the doctrine as promoting the integrity of the patent
system as a deontological end in itself. See id. at 746-47.
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administrative costs-again, the model is intended principally as positive or
explanatory, not normative-it demonstrates some ways in which various doctrinal
changes, either by themselves or in combination, might be expected to reduce the
negative consequences that critics claim the doctrine has generated. Finally, the
model suggests that the social value of an inequitable conduct doctrine may be
greater in a regime like that of the United States, which lacks an effective system
for post-grant oppositions. Conversely, if the United States adopted a post-grant
opposition system, the need for a robust inequitable conduct doctrine would
decline.
I. DOCTRINAL CONTOURS
By many accounts, the inequitable conduct doctrine has its origins in
three mid-twentieth century U.S. Supreme Court decisions in which the Court held
that the patents at issue were unenforceable because the patent owners had
engaged in some sort of fraudulent conduct in the course of procuring or litigating
their patents.' 3 Lower courts thereafter developed different tests for determining
whether the patent owner or applicant had engaged in inequitable conduct, thus
rendering the patent unenforceable. 14 Independent from these developments, the
USPTO in 1977 promulgated Patent Rule 56, which imposed on patent applicants
and persons associated with them a duty to disclose "information they are aware of
which is material to the examination of the application."' 5 Rule 56 defined
13. See Precision Instrument Mfg. Co. v. Auto. Maint. Mach. Co., 324 U.S. 806,
819 (1945) (holding that, where patent owner had every reason to believe that purported
inventor had submitted false testimony during the course of an interference proceeding
relating to his dates of invention and conception, the resulting patent was rendered
unenforceable); Hazel-Atlas Glass Co. v. Hartford-Empire Co., 322 U.S. 238, 250 (1944)
(setting aside a judgment of patent infringement, where patent owner had caused the
publication of a trade journal article authored by its patent attorney but attributed to a
"disinterested expert" that falsely touted the subject invention's advances over the prior art,
and had used that article to deceive both the Patent Office and the district court on the issue
of patentability); Keystone Driller Co. v. Gen. Excavator Co., 290 U.S. 245, 246-47 (1933)
(affirming dismissal of complaint for patent infringement, where patent owner had
corrupted a witness and suppressed evidence of another's prior use in order to defend
against patent invalidity in a prior infringement action involving related patents). As in the
patent misuse cases, which the Court was deciding during roughly the same time period, in
these three cases the Court drew an analogy to the equitable doctrine of unclean hands.
Earlier patent law had recognized limited rights to cancel patents that were procured by
fraud. See Robert J. Goldman, Evolution of the Inequitable Conduct Defense in Patent
Litigation, 7 HARV. J.L. & TECH. 37, 39-45 (1993); McGowan, supra note 2, at 948-56;
Sean M. O'Connor, Defusing the "Atomic Bomb" of Patent Litigation: Avoiding and
Defending Against Allegations of Inequitable Conduct After McKesson et al., 9 J.
MARSHALL REV. INTELL. PROP. L. 330, 331-33 (2010).
14. See, e.g., Plastic Container Corp. v. Cont'l Plastics, Inc., 607 F.2d 885, 899-
901 (10th Cir. 1979); Norton v. Curtiss, 433 F.2d 779, 791-97 (C.C.P.A. 1970). For
discussion of post-Precision Instrument, pre-Federal Circuit case law, see Goldman, supra
note 13, at 56-57; O'Connor, supra note 13, at 340-44, 352; Gerald Sobel, Reconsidering
the Scope of the Inequitable Conduct Doctrine in View of Supreme Court Precedent and
Patent Policy, 18 FED. CIR. B.J. 169, 172-74 (2009).
15. 37 C.F.R. § 1.56 (1977). An earlier version of Rule 56 merely authorized the
USPTO to strike an application that was "fraudulently filed or in connection with which any
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information as material if "there is a substantial likelihood that a reasonable
examiner would consider it important in deciding whether to allow the application
to issue as a patent."'16 The USPTO's amended version of Rule 56, which went into
effect in 1992, similarly imposes on "[e]ach individual associated with the filing
and prosecution of a patent application... a duty to disclose to the Office all
information known to that individual to be material to patentability,"' 7 while also
providing a more detailed definition of materiality. Specifically, the current
version of Rule 56 states that information is material if "it is not cumulative to
information already of record or being made of record in the application," and it
either "establishes, by itself or in combination with other information, a prima
facie case of unpatentability of a claim" or "refutes, or is inconsistent with, a
position the applicant takes in ... [o]pposing an argument of unpatentability relied
on by the Office, or... [a]sserting an argument of patentability."' 8 Rule 56 further
specifies that "no patent will be granted on an application in connection with
which fraud on the Office was practiced or attempted or the duty of disclosure was
violated through bad faith or intentional misconduct."1 9
Since its formation in the early 1980s, the Federal Circuit has drawn on
these various sources to fashion its own version of an inequitable conduct defense
that sometimes applies to conduct significantly less egregious than the misconduct
that was at issue in the Supreme Court trilogy. Illustrating how the doctrine
operates under current law requires a short foray into the workings of patent
prosecution and litigation. Briefly stated, to begin the process of obtaining a
patent, the inventor files a patent application with the USPTO.2 ° The USPTO then
assigns an examiner to determine whether the application meets the statutory
requirements for patentability-among them, whether the application recites
patentable subject matter,2' whether the claimed invention is both novel and
nonobvious in light of the relevant prior art,22 and whether the application
fraud [was] practiced or attempted on the Patent Office." O'Connor, supra note 13, at 338
(quoting 37 C.F.R. § 1.56 (1949)).
16. 37 C.F.R. § 1.56 (1977).
17. 37 C.F.R. § 1.56(a) (2009). In the wake of the recent en banc Therasense
decision, discussed below, the USPTO has proposed a revision to the Rule 56 materiality
standard that tracks Therasense. See Revision to the Materiality Standard for the Duty to
Disclose Information in Patent Applications, 76 Fed. Reg. 43631 (July 21, 2011).
18. 37 C.F.R. § 1.56(b) (2009). The rule goes on to state:
A prima facie case of unpatentability is established when the information
compels a conclusion that a claim is unpatentable under the
preponderance of evidence, burden-of-proof standard, giving each term
in the claim its broadest reasonable construction consistent with the
specification, and before any consideration is given to evidence which
may be submitted in an attempt to establish a contrary conclusion of
patentability.
Id. § 1.56(b)(2)(ii).
19. Id. § 1.56(a).
20. See 35 U.S.C. § 1 I (a) (2006).
21. See 35 U.S.C. § 101 (2006); Bilski v. Kappos, 130 S. Ct. 3218, 3225 (2010).
22. See 35 U.S.C. §§ 102, 103 (2006).
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conforms to Patent Act § 112.23 Ostensibly, to assist the examiner in making this
determination, Rule 56 (as noted above) requires the inventor to disclose material
information, either in the body of the patent application or in a document known as
an "Information Disclosure Statement" or "IDS. '24 If the inventor is successful in
obtaining a patent, she is then free to file suit against anyone she has reason to
believe is making, using, or selling the invention without authorization.
25
Suppose, then, that inventor P files suit against defendant D for
infringement. In defense, D typically will first assert that he is not infringing; for
example, D may contend that, contrary to P's allegations, D's products or services
do not fall within the scope of any of the patent's claims. Second, D is likely to
assert that, even if his products fall within the scope of one or more of the patent's
claims, D's conduct is lawful because the claims themselves are invalid. D may
contend, among other things, that during the course of patent prosecution the
examiner overlooked or failed to appreciate the significance of certain prior art
references demonstrating that the invention lacked novelty or was obvious; or that
the claims do not recite patentable subject matter; or that the specification fails to
conform to § 112.26 A third possible defense is that, even if the patent is both valid
27and infringed, it remains unenforceable by reason of inequitable conduct. To
understand how this defense differs from invalidity requires an exploration of a
fairly complex body of Federal Circuit case law.
According to the Federal Circuit, inequitable conduct encompasses both
the intentional submission of materially false information and the failure to
disclose material information. More precisely, the substantive elements of
inequitable conduct are: "(1) an individual associated with the filing and
prosecution of a patent application made an affirmative misrepresentation of a
material fact, failed to disclose material information, or submitted false material
information; and (2) the individual did so with a specific intent to deceive the
23. As interpreted by the courts, § 112 requires the applicant to provide a written
description demonstrating that the inventor is in possession of the claimed subject matter,
Ariad Pharm., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. Cir. 2010) (en banc); to
enable a person of skill in the art to make and use the invention, id. at 1343 (quoting 35
U.S.C. § 112 (2006)); to reveal the inventor's best mode, if any, of carrying out the
invention, id; and to "conclude with one or more claims particularly pointing out and
distinctly claiming the subject matter which the applicant regards as his invention," 35
U.S.C. § 112, para. 2. The claims therefore define the boundaries of the invention; the
typical patent contains multiple claims relating to various aspects of the invention.
24. See 37 C.F.R. §§ 1.97, 1.98 (2009).
25. See 35 U.S.C. § 271(a) (2006).
26. Patents are presumed valid, 35 U.S.C. § 282 (2006), and the defendant has
the burden of proving invalidity by clear and convincing evidence, Microsoft Corp. v. i4i
Ltd. P'ship, 131 S. Ct. 2238, 2242 (2011). Nevertheless, statistics show that defendants are
successful in proving invalidity-essentially, that the USPTO made a mistake in issuing one
or more claims of the patent-almost 50% of the time. See John R. Allison & Mark A.
Lemley, Empirical Evidence on the Validity of Litigated Patents, 26 AIPLA Q.J. 185, 205-
07 (1998).
27. Other possible defenses not relevant to the present discussion include patent
misuse, laches, and implied license.
744 ARIZONA LAW REVIEW [VOL. 53:735
PTO."28 Difficulties arise, however, in trying to define these elements of
materiality and intent with any degree of precision.
As for materiality, prior to Therasense the Federal Circuit had retained all
five of the standards reflected in pre-Federal Circuit case law, the 1977 version of
Rule 56, and the 1992 version of Rule 56. These five standards included: (1) an
objective but-for test (i.e., the patent should not have issued absent the fraud); (2) a
subjective but-for standard (i.e., the patent would not have issued absent the fraud);
(3) a but-it-may-have standard (i.e., the fraud may have affected the issuance of the
patent); (4) the reasonable examiner standard as set forth in original Rule 56 (i.e.,
there is a substantial likelihood that a reasonable examiner would have considered
the omitted reference important in deciding patentability); and (5) the current Rule
56 standard (i.e., the information is material in the sense of establishing a prima
facie case of unpatentability, or refuting or being inconsistent with a position the
applicant takes regarding patentability before the USPTO).29 According to one
panel, however, because the "reasonable examiner" standard is the broadest of
these standards, it gradually had become "the sole standard invoked by this court,"
though "in no way did it supplant or replace the case law precedent."
30
The Federal Circuit's Therasense decision, handed down in May 2011,
revised the court's governing standards on materiality by holding that "as a general
matter, the materiality required to establish inequitable conduct is but-for
materiality." 31 More specifically:
28. Exergen Corp. v. Wal-Mart Stores, Inc., 575 F.3d 1312, 1327 n.3 (Fed. Cir.
2009) (citing Star Scientific, Inc. v. R.J. Reynolds Tobacco Co., 537 F.3d 1357, 1365 (Fed.
Cir. 2008)). The Federal Circuit reaffirmed this definition of inequitable conduct in
Therasense. See Therasense, Inc. v. Becton, Dickinson & Co., Nos. 2008-1511, -1512,
-1513, -1514, -1595, 2011 WL 2028255, at *6 (Fed. Cir. May 25, 2011) (en banc). The
defendant must plead the defense with particularity pursuant to Federal Rule of Civil
Procedure 9(b), see Exergen, 575 F.3d at 1318, and must prove the two elements of intent
and materiality by clear and convincing evidence, see Therasense, 2011 WL 2028255, at
*6; Larson Mfg. Co. v. Aluminart Prods. Ltd., 559 F.3d 1317, 1344 (Fed. Cir. 2009).
29. See Digital Control Inc. v. Charles Mach. Works, 437 F.3d 1309, 1314-16
(Fed. Cir. 2006).
30. Id. at 1316.
31. Therasense, 2011 WL 2028255, at *11. Chief Judge Rader's majority
opinion was joined by Judges Newman, Lourie, Linn, Moore, and Reyna. Judge O'Malley
filed a separate opinion concurring in the majority's resolution of the "intent" issue but
dissenting from its resolution of "materiality." Under Judge O'Malley's proposed standard,
conduct would be material where:
(1) but for the conduct (whether it be in the form of an affirmative act or
intentional non-disclosure), the patent would not have issued... ; (2) the
conduct constitutes a false or misleading representation of fact (rendered
so either because the statement made is false on its face or information is
omitted which, if known, would render the representation false or
misleading); or (3) the district court finds that the behavior is so
offensive that the court is left with a firm conviction that the integrity of
the PTO process as to the application at issue was wholly undermined.
Id. at *20 (O'Malley, J., concurring in part and dissenting in part). In dissent, Judge Bryson,
joined by Judges Gajarsa, Dyk, and Prost, argued for adoption of the USPTO's 1992
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When an applicant fails to disclose prior art to the PTO, that prior
art is but-for material if the PTO would not have allowed a claim
had it been aware of the undisclosed prior art. Hence, in assessing
the materiality of a withheld reference, the court must determine
whether the PTO would have allowed the claim if it had been aware
of the undisclosed reference. In making this patentability
determination, the court should apply the preponderance of the
evidence standard and give claims their broadest reasonable
construction .... Often the patentability of a claim will be congruent
with the validity determination-if a claim is properly invalidated in
district court based on the deliberately withheld reference, then that
reference is necessarily material because a finding of invalidity in a
district court requires clear and convincing evidence, a higher
evidentiary burden than that used in prosecution at the PTO.
However, even if a district court does not invalidate a claim based
on a deliberately withheld reference, the reference may be material
if it would have blocked patent issuance under the PTO's different
evidentiary standards.32
Two ambiguities nevertheless remain. First, it is not entirely clear from
the opinion whether the majority intended to adopt the "objective" or the
"subjective" but-for test as the governing standard for materiality. On the one
hand, the majority's frequent use of the word "would" (as opposed to "should")
might suggest that it was opting for the subjective test. On the other hand, the
majority's further statement that a reference is "necessarily" material "if a claim is
properly invalidated in district court based on the ... reference" 33 would seem
more consistent with the objective test; the mere fact that a court properly found
the reference to be invalidating does not "necessarily" indicate that the actual
examiner, as opposed to a hypothetical ideal examiner, would have made the same
finding.34 Second, the majority recognized an exception to the but-for rule "in
cases of affirmative egregious misconduct" such as "the filing of an unmistakably
false affidavit." 35  Because the exception applies only to affirmative
misrepresentations and not omissions,3 it may have relatively infrequent
application37 -though for now that conclusion is far from certain. In dissent, Judge
Bryson cited the example of "a submission to the PTO that purports to describe the
materiality standard. See id. at *22 (Bryson, J., dissenting).
32. Id. at *11 (majority opinion) (citations omitted).
33. Id.
34. For defense of my pairing of the terms "subjective but-for" with the actual
examiner, and of "objective but-for" with a hypothetical ideal examiner, see infra text
accompanying note 92.
35. Therasense, 2011 WL 2028255, at *12. The majority appears to see such
conduct as implicating the traditional equitable doctrine of unclean hands. See id. at *6,
*12-13.
36. See id. at *12 ("Because neither mere nondisclosure of prior art references to
the PTO nor failure to mention prior art references in an affidavit constitutes affirmative
egregious misconduct, claims of inequitable conduct that are based on such omissions
require proof of but-for materiality.").
37. See Petherbridge et al., supra note 2, at 34 ("[O]mission ... is far and away
the most common form of material conduct described in Federal Circuit opinions.").
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state of the prior art but knowingly omits the closest prior art" as evidence that "it
is often difficult to draw a line between nondisclosure and affirmative
misrepresentation" and predicted that "[t]he distinction between 'affirmative acts'
and 'nondisclosure' is thus apt to become fertile ground for litigation in the future,
not to mention the distinction between 'egregious' misconduct and misconduct that
is assuredly less than 'egregious.'38
As for the intent element, over 20 years ago in Kingsdown Medical
Consultants, Ltd. v. Hollister Inc., 9 the Federal Circuit held en banc that a
defendant asserting inequitable conduct must prove intent to deceive and not
merely gross negligence on the part of the patent applicant.40 Subsequent case law
nevertheless muddied the waters by adopting conflicting views on the precise
meaning of "intent to deceive." One line of Federal Circuit cases interpreted
Kingsdown to mean that, while intent could be inferred from circumstantial
evidence, neither gross negligence nor the materiality of the information withheld
was, by itself, sufficient evidence of intent. 41 A competing line of cases held that
the trier of fact could infer intent to deceive where the omitted information was
highly material, the party who failed to disclose the information knew or should
have known of its materiality, and that party offered no credible explanation for
failing to disclose it.42 Critics argued that this latter line of authority could not be
reconciled with Kingsdown, because a "knew or should have known" standard
would allow the trier of fact to infer intent to deceive on the basis of mere
negligence (not even amounting to gross negligence). 43 Further compounding the
38. Therasense, 2011 WL 2028255, at *33 n.3 (Bryson, J., dissenting); see also
id. at * 18 n.3 (O'Malley, J., concurring in part and dissenting in part) ("If 'unclean hands'
remains available in cases of PTO misconduct, charges of unclean hands could simply
supplant the very allegations of inequitable conduct the majority seeks to curb.").
39. 863 F.2d 867 (Fed. Cir. 1988) (en banc).
40. Id. at 876.
41. See, e.g., Abbott Labs. v. Sandoz, Inc., 544 F.3d 1341, 1355-56 (Fed. Cir.
2008).
42. See, e.g., Praxair, Inc. v. ATMI, Inc., 543 F.3d 1306, 1313-14 (Fed. Cir.
2008); Ferring B.V. v. Barr Labs., Inc., 437 F.3d 1181, 1191 (Fed. Cir. 2006); cf Cancer
Research Tech. Ltd. v. Barr Labs., Inc., 625 F.3d 724, 733-34 (Fed. Cir. 2010) ("A court
cannot simply infer that an applicant 'should have known' the materiality of withheld
information and thus intended to deceive the PTO because the applicant knew of the
information and the information is material. A district court must find some other evidence
that indicates that the applicant appreciated the information's materiality." (citation
omitted)); Optium Corp. v. Emcore Corp., 603 F.3d 1313, 1321 (Fed. Cir. 2010)
("[C]onsistent precedent has rejected the notion that the materiality of a reference alone can
suffice to prove deceptive intent." (citations omitted)).
43. See, e.g., Larson Mfg. Co. v. Aluminart Prods. Ltd., 559 F.3d 1317, 1343-44
(Fed. Cir. 2009) (Linn, J., concurring); Mammen, supra note 2, at 1391-92. Arguably, the
"knew or should have known" standard was an inadvertent throwback to pre-Kingsdown
law. See Erik R. Puknys & Jared D. Schuettenhelm, Application of the Inequitable Conduct
Doctrine After Kingsdown, 25 SANTA CLARA COMPUTER & HIGH TECH. L.J. 839, 850-51
(2009) (noting that the Federal Circuit in Critikon, Inc. v. Becton Dickinson Vascular
Access, Inc., 120 F.3d 1253, 1256 (Fed. Cir. 1997), cited a pre-Kingsdown case, Driscoll v.
Cebalo, 731 F.2d 878 (Fed. Cir. 1984), for the "knew or should have known" standard);
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confusion, some decisions referred to the intent and materiality standards as
involving a "sliding scale," in the sense that a stronger showing of intent would
allow a finding of inequitable conduct on a somewhat lower showing of
materiality, and vice versa. 44
Therasense has now clarified the intent to deceive element by expressly
holding that the appropriate standard is "specific intent to deceive," not negligence
or gross negligence,45 and by rejecting the "sliding scale. 46 Recognizing that
"direct evidence of deceptive intent is rare," however, the Therasense majority
conceded that "a district court may infer intent from indirect and circumstantial
evidence" while also citing with approval prior case law holding that "to meet the
clear and convincing evidence standard, the specific intent to deceive must be 'the
single most reasonable inference able to be drawn from the evidence'--indeed,
the evidence must "require a finding of deceitful intent in the light of all the
circumstances. 47 Some ambiguity in the application of the new standard
nevertheless may remain at the margin. In her concurring opinion, for example,
Judge O'Malley stated her understanding that a court may still "consider the level
of materiality as circumstantial evidence in its intent analysis," even though it must
"reach separate conclusions of intent and materiality and may not base a finding of
specific intent to deceive on materiality alone, regardless of the level of
materiality., 48 In a similar vein, Judge Bryson suggested that it remains
appropriate to "consider[] the degree of materiality as relevant to the issue of
intent.., particularly given that direct evidence of intent, such as an admission of
deceptive purpose, is seldom available. 4 9 The majority did not respond directly to
the concurring or dissenting opinion on this particular issue; thus, the question of
the precise relationship between materiality and intent remains to be determined.
Therasense appears to leave the inequitable conduct doctrine unchanged
in all other respects. First, nothing in Therasense reverses prior case law holding
that, if the defendant makes the requisite showing of both intent and materiality,
the district court should engage in a balancing test to determine whether the
Brett J. Thompsen, Note, Resolving Inequitable Conduct Claims According to Kingsdown,
18 TEX. INTELL. PROP. L.J. 269, 275-76 (2010) (same).
44. See, e.g., Abbott Labs. v. TorPharm, Inc., 300 F.3d 1367, 1380 (Fed. Cir.
2002); Critikon, 120 F.3d at 1256. Nevertheless, the defendant was supposed to prove by
clear and convincing evidence that each element met the minimum threshold of both intent
and materiality. See AstraZeneca Pharm. LP v. .Teva Pharm. USA, Inc., 583 F.3d 766, 776
(Fed. Cir. 2009). For a helpful visual depiction, see Mammen, supra note 2, at 1344.
45. Therasense, Inc. v. Becton, Dickinson & Co., Nos. 2008-1511, -1512, -1513,
-1514, -1595, 2011 WL 2028255, at *9 (Fed. Cir. May 25, 2011) (en banc). All eleven
active members of the court agreed on this holding. Id. at *17 (O'Malley, J., concurring in
part and dissenting in part); id. at *22 (Bryson, J., dissenting).
46. Id. at *10 (majority opinion). All eleven judges agreed on this point as well.
Id. at *17 (O'Malley, J., concurring in part and dissenting in part); id. at *22 (Bryson, J.,
dissenting).
47. Id. at *10 (majority opinion) (quoting Kingsdown Med. Consultants, Ltd. v.
Hollister Inc., 863 F.2d 867, 873 (Fed. Cir. 1988) (en banc)).
48. See id. at * 17 n. I (O'Malley, J., concurring in part and dissenting in part).
49. Id. at *24 n. I (Bryson, J., dissenting).
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applicant committed inequitable conduct. ° Second, Therasense reaffirms that a
district court's factual findings on intent and materiality are subject to appellate
review only for clear error.5' Third, Therasense appears to leave intact the rule that
whether conduct meeting the minimal thresholds of materiality and intent should
be characterized as "inequitable" is a matter entrusted to the district court's
equitable discretion, reviewable on appeal for abuse of discretion.52
Fourth, and most importantly, the practical significance of the doctrine
continues to reside in the penalty that follows from a finding of inequitable
conduct. Even after Therasense, a finding of inequitable conduct renders the entire
patent 53 -and sometimes even related patents5 4-unenforceable. As a
consequence, even when the plaintiff fails to prove infringement or the defendant
succeeds in proving the invalidity of some or all of the claims at issue, a court will
typically go on to consider the merits of a properly raised inequitable conduct
defense. If successful, this challenge will render all of the claims of the patent
unenforceable-not only against the defendant who raised the defense, but also
against any other potential infringer. At least in this respect, the inequitable
conduct doctrine remains, in Chief Judge Rader's words, the "atomic bomb" of
patent litigation.
55
50. See AstraZeneca Pharm. LP v. Teva Pharm. USA, Inc., 583 F.3d 766, 776
(Fed. Cir. 2009).
51. 2011 WL 2028255, at *10.
52. See id. at *24 (Bryson, J., dissenting); see also id. at *10 (majority opinion)
(indicating that courts retain discretion not to find inequitable conduct, even when the
threshold showings of materiality and intent are present); Abbott Labs. v. Sandoz, Inc., 544
F.3d 1341, 1353 (Fed. Cir. 2008) (quoting Kingsdown, 863 F.2d at 876).
53. 2011 WL 2028255, at *12. In addition, a finding of inequitable conduct can
result in a finding that a case is exceptional and, therefore, that the defendant is entitled to
attorney's fees. See id. at *8; Aspex Eyewear Inc. v. Clariti Eyewear, Inc., 605 F.3d 1305,
1315 (Fed. Cir. 2010); Taltech Ltd. v. Esquel Enters. Ltd., 604 F.3d 1324, 1328 (Fed. Cir.
2010); Wedgetail, Ltd. v. Huddleston Deluxe, Inc., 576 F.3d 1302, 1304-05 (Fed. Cir.
2009). In contrast to the misuse doctrine, the inequitable conduct doctrine does not envision
any way for the patentee to purge its misconduct and thus restore the patent's enforceability.
54. On the doctrine of "infectious unenforceability," compare Fox Industries v.
Structural Preservation Systems, Inc., 922 F.2d 801, 804 (Fed. Cir. 1990) ("[A] breach of
the duty of candor early in the prosecution may render unenforceable all claims which
eventually issue from the same or a related application."), with Baxter International, Inc. v.
McGaw, Inc., 149 F.3d 1321, 1332 (Fed. Cir. 1998) ("[W]here the claims are subsequently
separated from those tainted by inequitable conduct through a divisional application, and
where the issued claims have no relation to the omitted prior art, the patent issued from the
divisional application will not also be unenforceable due to inequitable conduct committed
in the parent application.").
55. Therasense, 2011 WL 2028255, at *8. Adoption of the objective but-for
standard, however-assuming that this is the standard the court has adopted, and ignoring
for now the exception for affirmative misrepresentations-will obviate one consequence
associated with the other four materiality standards, namely the possibility of rendering a
patent unenforceable by reason of the applicant's failure to disclose references that would
have had no effect on validity. To illustrate, suppose that a court finds that P intentionally
failed to disclose a prior art reference that, on its face, suggests that her invention may have
been obvious at the time of invention to a person of ordinary skill in the art, see 35 U.S.C. §
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Prior to Therasense, the complexity and operation of the inequitable
conduct doctrine had generated intense criticism from some members of the patent
community. Critics argued that the multiplicity of possible standards, as well as the
corresponding inconsistencies in the case law, often made it irresistible for
defendants to avoid raising the defense.56 In addition, some critics noted a risk of
103(a) (2006), but that P would have been able to "traverse" (distinguish) the reference
through persuasive argument or other evidence of patentability. In such a case, under pre-
Therasense law the patent may well have been valid but unenforceable as a result of P's
failure to disclose the suggestive, though ultimately non-invalidating, reference.
Alternatively, P may have failed to disclose information that a reasonable examiner might
have considered relevant, though ultimately non-invalidating, to various other patentability
requirements such as subject matter, enablement, or best mode. See infra note 63 and
accompanying text.
Yet another example would be information that has no bearing at all on patentability as
such, but that relates instead to the inventor's entitlement to various prosecution-related
benefits. Pre-Therasense, the Federal Circuit had held that misrepresentations relating to so-
called "petitions to make special," otherwise known as petitions for expedited examination,
U.S. PATENT & TRADEMARK OFFICE, U.S. DEP'T OF COMMERCE, MANUAL OF PATENT
EXAMINING PROCEDURE § 708.02 (Magdalen Greenlief ed., 8th ed., rev. July 2010), or to a
patent owner's small entity status (rendering the applicant eligible to pay lower examination
fees), could be the basis of a finding of inequitable conduct, see Scanner Techs. Corp. v.
ICOS Vision Sys. Corp. N.V., 528 F.3d 1365, 1375 (Fed. Cir. 2008) ("When the setting
involves a petition to make special.., a false statement that succeeds in expediting the
application is, as a matter of law, material for purposes of assessing the issue of inequitable
conduct." (footnote omitted)); Nilssen v. Osram Sylvania, Inc., 504 F.3d 1223, 1231-32
(Fed. Cir. 2007) ("While a misrepresentation of small entity status is not strictly speaking
inequitable conduct in the prosecution of a patent, as the patent has already issued if
maintenance fees are payable (excepting an issue fee), it is not beyond the authority of a
district court to hold a patent unenforceable for inequitable conduct in misrepresenting
one's status as justifying small entity maintenance payments." (citation omitted)); see also
Ulead Sys., Inc. v. Lex Computer & Mgmt. Corp., 351 F.3d 1139, 1144 (Fed. Cir. 2003)
("Historically issues of unenforceability have arisen in cases involving inequitable conduct
occurring in the prosecution of patents. But, we see no reason why the doctrine should not
extend into other contexts, like the present one, where the allegation is that inequitable
conduct has occurred after the patent has issued and during the course of establishing and
paying the appropriate maintenance fee. In this context, it is equally important that the PTO
receive accurate information from those who practice before it." (citation omitted)). The
court had also held that failure to disclose related litigation involving a parent patent, as
required under § 2001.06(c) of the Manual of Patent Examining Procedure, was material
even if the patentee prevailed in that litigation. Leviton Mfg. Co. v. Universal Sec.
Instruments, Inc., 606 F.3d 1353, 1362 (Fed. Cir. 2010); see also McKesson Info. Solutions,
Inc. v. Bridge Med., Inc., 487 F.3d 897, 919-26 (Fed. Cir. 2007) (affirming findings of
materiality and intent with respect to failures to disclose rejections in co-pending
application, and examiner's own prior allowance of claims in a related application).
Presumably the holdings in the cases cited in this paragraph survive Therasense where the
applicant has engaged in affirmative misrepresentations, but not where the applicant merely
fails to disclose.
56. See Larson Mfg. Co. v. Aluminart Prods. Ltd., 559 F,3d 1317, 1342 (Fed.
Cir. 2009) (Linn, J., concurring); see also NAT'L RESEARCH COUNCIL, supra note 2, at 122;
Cotropia, supra note 2, at 739-41; Wasserman, supra note 2, at 14-15. While few observers
would defend an inventor's right to make affirmative misrepresentations to the patent office,
as noted above, the vast majority of inequitable conduct allegations related to the broader,
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"hindsight bias" in determining, at the time of trial, whether the applicant knew at
the time of prosecution that information she chose to withhold was material;
attempts to explain, during the course of litigation many years later, why the
information did not appear material at the time of prosecution may sound
unconvincing.57 Others contended that the doctrine induced patent applicants to
disclose far more information than was necessary-indeed, more than a patent
examiner could be expected to review and comprehend-simply to reduce the
probability of a subsequent finding of inequitable conduct.58 As a consequence, the
doctrine may have raised the cost of litigation by encouraging accused infringers to
conduct fishing expeditions to determine whether the patentee failed to call some
arguably relevant piece of information to the attention of the patent examiner. 59 At
the very least, if the critics were right, an overly expansive inequitable conduct
doctrine raised the cost of patent prosecution to some degree, often with very little
corresponding social benefit.
There are other criticisms related to the all-or-nothing nature of the
penalty for inequitable conduct. Several observers have argued that rendering all
claims of the affected patent unenforceable-including claims that themselves
were unrelated to the alleged fraud, and potentially even claims of other, related
and less easily containable, category of failures to disclose material information. See supra
note 37 and accompanying text.
57. See Feldman, supra note 2, at 17, 20-22; Murphy, supra note 2, at 2274.
58. See, e.g., S. REP. No. 110-259, at 32 n.152 (2008); FED. TRADE COMM'N,
supra note 2, at 11- 12; SECTION OF INTELLECTUAL PROP. LAW, AM. BAR ASS'N, supra note
2, at 2; Armitage, supra note 2, at 2-3; Cotropia, supra note 2, at 770-73 (discussing
information overload); Hatch, supra note 2, at 516 (referring to the production of boxes of
documents); Brown, supra note 2, at 618-20 (describing testimony presented at Patent
Reform Act hearings); Murphy, supra note 2, at 2293. The majority in Therasense accorded
this purported overdisclosure phenomenon considerable weight in its decision to alter the
materiality standard. 2011 WL 2028255, at *9. But see McGowan, supra note 2, at 979
(questioning the information overload argument); Petherbridge et al., supra note 2, at 41,
54-55 (noting reasons applicants may choose not to disclose, notwithstanding the risk of
unenforceability, and questioning whether burdensome disclosure obligations provide a
compelling reason for substantially modifying the doctrine); Christopher A. Cotropia et al.,
Do Applicant Patent Citations Matter? Implications for the Presumption of Validity 15-16,
19-25 (Stanford Law & Econ., Working Paper No. 401, 2010), available at
http://ssm.com/abstract--1656568 (presenting empirical evidence that examiners tend to
ignore applicant-submitted art, even when it is likely to be relevant to patentability).
59. See SECTION OF INTELLECTUAL PROP. LAW, AM. BAR Ass'N, supra note 2, at
2; Armitage, supra note 2, at 2. A more subtle consequence is that fears of incurring a
charge of inequitable conduct may discourage some patent applicants from filing so-called
Rule 131 affidavits. See Dennis D. Crouch, Is Novelty Obsolete? Chronicling the
Irrelevance of the Invention Date in U.S. Patent Law, 16 MICH. TELECOMM. & TECH. L.
REv. 53, 97-98 (2009). Patent Rule 131 allows the applicant to "swear behind" a prior art
reference-that is, to assert a date of invention prior to a reference that otherwise may
anticipate or render obvious the applicant's invention-and thus helps to promote the U.S.
policy of awarding patents to the first to invent (as opposed to the "first to file" rule the rest
of the world follows). In this respect, an expansive or uncertain inequitable conduct doctrine
would tend to undermine one aspect of U.S. patent policy. I thank Rebecca Eisenberg for
bringing this point to my attention.
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patents-is often disproportionate to the magnitude of the offense, 60 and that a
more sensible approach would permit courts to select from a range of penalties
(e.g., partial enforceability, temporary enforceability, awarding damages only, or
assessing attorney sanctions only).6' In her concurring opinion in Therasense,
Judge O'Malley argues in favor of this option,62 though perhaps the definitions of
materiality and intent adopted in the majority opiniqn will reduce this reform's
perceived urgency. 63 As suggested above, however, even after Therasense several
60. See New Medium LLC v. Barco N.V., 582 F. Supp. 2d 991, 999 (N.D. Ill.
2008) (Posner, J., sitting by designation), vacated by agreement of parties, No. 05 C 5620,
2009 WL 2385890 (N.D. Ill. May 15, 2009); Armitage, supra note 2, at 1; Wasserman,
supra note 2, at 17-18; Murphy, supra note 2, at 2274.
61. See, e.g., S. REP. No. 110-259, at 33 (2008); McElhone, supra note 2, at 408-
09; McGowan, supra note 2, at 979-80; Murphy, supra note 2, at 2296-2302; see also
Wasserman, supra note 2, at 18-22 (proposing a "second tier of remedies for less offensive
behavior").
62. 2011 WL 2028255, at *19 (O'Malley, J., concurring in part and dissenting in
part) ("We should recognize that determining the proper remedy for a given instance of
inequitable conduct is within the discretion of district courts .... [A] district court may
choose to render fewer than all claims unenforceable.., simply dismiss the action before it,
or... fashion some other reasonable remedy, so long as the remedy imposed by the court is
'commensurate with the violation."' (citation omitted)).
63. Under pre-Therasense doctrine, a finding of inequitable conduct could
sometimes result from what might be termed "near-misses," that is, from the applicant's
failure to disclose information that almost would have had a bearing on patentability. To
illustrate, suppose that an applicant intentionally failed to disclose some piece of
information that arguably could be deemed relevant to carrying out her best mode of
practicing the invention, but ultimately the defendant was unable to prove a best mode
violation by the requisite clear and convincing evidence. Because compliance with the best
mode requirement is a necessary precondition to a valid patent, intentionally withholding
one's best mode can constitute a material omission and thus qualify as inequitable conduct.
See Consol. Aluminum Corp. v. Foseco Int'l Ltd., 910 F.2d 804, 808-09 (Fed. Cir. 1990).
And, while the applicant's failure to disclose in this hypothetical would not be deemed
material under an objective but-for test or, most likely, under the 1992 version of Rule 56,
the question could be close enough that the examiner would have rejected the application,
had she known the facts (materiality standard 2); failure to disclose may have affected
issuance of the patent (materiality standard 3); and a reasonable examiner might have
considered the omitted information "important" (materiality standard 4). Thus, it is possible
that the omission might have constituted inequitable conduct, even if there is no actual best
mode violation (and even though questions of compliance with the best mode requirement
rarely arise during patent prosecution). See U.S. PATENT & TRADEMARK OFFICE, U.S. DEP'T
OF COMMERCE, supra note 55, § 2165.03 ("It is extremely rare that a best mode rejection
properly would be made in ex parte prosecution. The information that is necessary to form
the basis for a rejection based on the failure to set forth the best mode is rarely accessible to
the examiner, but is generally uncovered during discovery procedures in interference,
litigation, or other inter partes proceedings."). Given the criticism that some observers have
leveled against the best mode doctrine generally, see NAT'L RESEARCH COUNCIL, supra note
2, at 120-21 (suggesting that that the penalty of invalidity is often disproportionate to the
value of the withheld information, given that the inventor's best mode as of the date of
filing may have little relevance to the practice of the invention many years later, and the
absence of a best mode doctrine in any other country's patent system), one might question
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issues surrounding the definitions of materiality and intent remain undetermined;
nor is it clear that Therasense itself will be the last word on materiality and intent.
The need for a clearer analytical framework remains.
II. A FORMAL MODEL OF THE INEQUITABLE CONDUCT DOCTRINE
Although a more traditional view would locate the inequitable conduct
doctrine in considerations of ethics and-as the name of the doctrine implies-
equity, from an economic perspective the doctrine can be thought of as a tool for
encouraging patent applicants and their agents to disclose information to the
USPTO.64 More precisely, in theory, the doctrine could serve the purpose of
inducing the efficient disclosure of information that is relevant to patentability
(and perhaps other information as well, as discussed below). In this Part, I first
present a model of a socially optimal inequitable conduct doctrine. I then model
the applicant's incentive to disclose material information, as well as various
possible definitions of materiality, intent, and "balancing."
A. A Socially Optimal Inequitable Conduct Doctrine
To model a socially optimal inequitable conduct doctrine requires
consideration of two key points. First, the doctrine should induce the applicant to
disclose a preexisting,65 relevant 66 unit 67 of information I-a potential prior art
whether it would ever make sense to allow accused infingers to leverage unsuccessful best
mode defenses into successful inequitable conduct defenses.
64. See Cotropia, supra note 2, at 754; McGowan, supra note 2, at 974.
65. In other words, the model above focuses on the more common situation of
alleged inequitable conduct arising from an applicant's failure to disclose existing
information, rather than from her affirmative misrepresentation or fabrication of evidence.
Penalizing the latter species of inequitable conduct poses fewer problems from a utilitarian
perspective, insofar as there is, presumably, no social benefit (and potentially considerable
private and social costs) from manufacturing evidence-though whether unenforceability is
always the appropriate penalty even in this instance, particularly given the risk of judicial
error, is a difficult question. Not every misrepresentation relates to patentability after all.
See supra note 55 (discussing misrepresentations as to small entity status and petitions to
make special). Of course, an applicant who misrepresents some material fact is also, by
necessity, failing to disclose relevant information of which she is aware (i.e., the true state
of the world as she understands it to be). In this sense, every misrepresentation also involves
a nondisclosure.
66. As the discussion below indicates, deciding what type of information should
be deemed "relevant" for purposes of the inequitable conduct doctrine-formally, what
information comprises the set S discussed in the text above-is not easy. The 1992 version
of Patent Rule 56 adopts a fairly narrow definition of relevance, for example, whereas the
"reasonable examiner" standard adopts a much broader one. Cf FED. R. Civ. P. 26(b)(1)
(generally authorizing the discovery of relevant evidence, even if not admissible at trial, if
its "discovery appears reasonably calculated to lead to the discovery of admissible
evidence"); FED. R. EVID. 401 (defining relevant evidence as "having any tendency to make
the existence of any fact that is of consequence ... more probable or less probable than it
would be without the evidence"); FED. R. EVID. 403 (authorizing courts to exclude relevant
evidence "if its probative value is substantially outweighed by ... considerations of undue
delay, waste of time, or needless presentation of cumulative evidence"). Analogously, one
could define the universe of information within set S as including, for example, all
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reference, for example, or information that could assist in enabling a person of
skill in the art to make or use the invention or to practice the inventor's best
mode-only if it is less costly for the applicant to disclose the information than it
would be for the examiner to find it herself.68 Second, on the assumption that the
applicant does enjoy a cost advantage over the examiner with respect to some set
of information I, the doctrine should induce disclosure only if, in addition, the
social benefit of disclosure (in terms of reducing the risk of issuing an invalid
patent) outweighs the social cost (in terms of processing information of only
marginal relevance).
As for the first point, formally the goal would be to design a standard that
would induce Applicant to reveal information I at time t, whenever
PExam [I E S] >X, (1)
and
CApp < CEx.., (2)
where tl is the date of filing; PEx,,m [1 e S] is the probability the examiner would
conclude that I falls into set S; CApp is Applicant's cost of disclosing I; and CExam is
the examiner's cost of discovering 1.69 Three obvious questions-which I will
merely note for now, but which will also be relevant to the inequitable conduct
doctrine's definition of materiality, as presented below 7°-are (1) whether PExam
should refer to the probability assigned by the actual examiner or by some
hypothetical examiner; (2) what sort of information comprises set S; and (3) the
value of x.
One matter to consider at this stage is whether the law would be improved
if the standard for inequitable conduct simply mirrored these criteria, properly
information that renders the patentability of the invention even slightly more or less
probable, or only information that is likely to affect patentability; one could include
information that reasonably could lead to the discovery of such information, or exclude
information that is cumulative; and so on.
67. The model proposes focusing on units of information such as individual prior
art references, rather than on larger aggregation of information (the proverbial boxloads of
documents that applicants sometimes submit in connection with IDSs, see Hatch, supra note
2, at 516). One reason to focus on individual documents is that this is what the courts do in
deciding whether a failure to disclose a specific reference constitutes inequitable conduct.
To be sure, individual applicants and their agents may not always have a specific probability
estimate as to the materiality of each such item of information; perhaps their probability
assessments operate at a rougher level of, say, classes or types of information. If so, one
might think of the probability corresponding to a given unit of information I as applying to
all such information within a given class of similar information. See infra note 84.
68. See Cotropia, supra note 2, at 754, 756.
69. As noted in Part I, disclosure may take the form of inclusion of I in the
application's written description (e.g., an enabling or best mode disclosure) or in an IDS.
The latter may include information on possibly relevant prior art, inventorship, or other
matters affecting patentability. Finally, as the term is used above, disclosure may mean not
misrepresenting or concealing facts relating to one's entitlement to certain privileges such
as small entity status or expedited examination (a petition to make special).
70. See infra Part II.C.
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defined.7' Some version of Expression (1), as discussed below, already constitutes
part of the materiality inquiry under current law.72 Incorporating Expression (2) as
a doctrinal requirement, however, seems impracticable. Taken literally, Expression
(2) would require the applicant to disclose I whenever it would be cheaper for the
applicant to disclose I than for the examiner to discover I; presumably this would
include some instances in which the applicant was not initially aware of I but,
through the exercise of reasonable effort, could have discovered (and disclosed) I
more cheaply than the examiner could have discovered it on his own. As such,
Expression (2) would contravene patent law's traditional reluctance to impose
upon applicants a duty to search for prior art of which they are not aware. Whether
imposing a duty to search would be desirable is debatable; 73 but for the foreseeable
future, the creation of such a duty would seem to be an unlikely development in
patent law.74 Second, even if it were possible to implement a duty to search,
determining whether the applicant or the examiner was the lower-cost discoverer
of information of which the applicant was not initially aware would surely be
difficult to determine in many cases. From a practical standpoint, such a standard
may not be much of an improvement over existing doctrine, at least as far as
certainty and predictability are concerned.
To overcome these problems, one might instead define CApp as the cost to
the applicant of disclosing relevant information of which she is aware; in such a
case, one would expect the applicant to be the lower-cost information provider.
75
Invoking the inequitable conduct doctrine whenever Expression (1) and (as
reinterpreted) Expression (2) are satisfied, therefore, might be viewed as the best
attainable means of inducing the lower-cost party to disclose relevant information,
even if such a standard falls short of the ideal. This standard would likely fall even
shorter of the ideal, however, given the difficulty and ambiguity (in some cases) of
determining whether the applicant was aware of information L Depending on how
the term "knowledge" is defined, such a standard could generate substantial
71. That is, one would still need to specify from whose point of view, and at
what time, PE would be determined; the content of S; and the value of x.
72. See infra Part II.C.
73. See, e.g., FED. TRADE COMM'N, supra note 2, ch. 5, at 11 (reviewing
competing views, and deciding not to recommend such a duty); Cotropia, supra note 2, at
779-81 (arguing against imposing such a duty).
74. See FED. TRADE COMM'N, supra note 2, ch. 5, at 11 (noting commentators'
skepticism over proposals to impose a duty to search). Although the 2007 Patent Reform
bills would have authorized the USPTO to impose a duty to search, the more recent bills
would not create such a duty; and to my knowledge no foreign patent system imposes such
a duty on applicants either. Moreover, as Christopher Cotropia notes, the imposition of a
duty to search is hard to reconcile with other proposals designed to make the inequitable
conduct doctrine less costly in its implementation. See Cotropia, supra note 2, at 744-46.
75. See Cotropia, supra note 2, at 754. But see Feldman, supra note 2, at 23
("Perhaps the burden of providing extensive prior art information rests too heavily on the
shoulders of the patent applicant, who is not in the best position psychologically to bear that
burden .... The solution may lie in finding others in the system who are better situated to
provide that perspective, either by allowing earlier intervention from adversaries or beefing
up the resources of the administrative experts.").
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administrative costs and thus undermine its proposed cost-saving rationale.
76
Perhaps more problematically, a requirement that applicants disclose any relevant
information of which they are aware could discourage some applicants from
exposing themselves to potential prior art. Analogous problems once arose in
connection with the law of enhanced damages, where, until recently, an accused
infringer's mere pre-infringement exposure to the patent at issue potentially
rendered the defendant liable for treble damages. 77 Partly in response to criticism
that this standard discouraged firms from reading patents, the Federal Circuit in
2007 held that patentees must prove both objective and subjective recklessness as a
precondition to a damages enhancement.78 In the present context, requiring the
defendant to prove more than mere knowledge on the part of the patentee as a
precondition to a finding of inequitable conduct similarly might be viewed as a
means for reducing the risk of abuse (in this case, on the part of defendants and not
patentees), though at the cost of moving yet further away from any clear
relationship to the policy of inducing the lower-cost party to disclose.
As for the second key point-maximizing the social benefit of the
applicant's disclosure over the social cost-the relevant inquiry can be illustrated
graphically. Figure 1 illustrates the difference between the privately and socially
optimal levels of disclosure in a system that induces some degree of
overdisclosure. (As noted above, critics argued that pre-Therasense doctrine had
precisely this effect. Figure 1 therefore should be viewed as a reflection of reality,
only if the doctrine's critics were right.) The x-axis denotes the quantity of
relevant 79 information of which the applicant is aware and which she discloses,
80
76. For example, would knowledge on the part of a low-ranking corporate
employee constitute knowledge on the part of the corporate assignee? Would an employee's
mere exposure to an existing patent impute constructive knowledge, on the part of the
employer, of the patent as prior art? In practice, the Rule 56 duty of candor extends only to
"[i]ndividuals associated with the filing and prosecution of a patent application," 37 C.F.R.
§ 1.56(c) (2009) (emphasis added); even so, questions do arise from time to time concerning
whether the duty of disclosure extended to the person who allegedly violated it, see, e.g.,
Avid Identification Sys., Inc. v. Crystal Imp. Corp., 603 F.3d 967, 973-77 (Fed. Cir. 2010)
(affirming finding that company president was "substantively involved" in prosecution and
therefore subject to the duty of candor). For somewhat differing perspectives on the
question of who should be subject to the duty, compare Mack, supra note 2, at 160-61,
173-74 (arguing in favor of retaining rule under which knowledge on the part of the patent
owner's representatives is imputed to the patent owner), with Armitage, supra note 2, at 2-3
(lamenting that, under current doctrine, innocent patent assignees sometimes wind up
suffering for applicants' misdeeds).
77. See Thomas F. Cotter, An Economic Analysis of Enhanced Damages and
Attorney's Fees for Willful Patent Infringement, 14 FED. CIR. B.J. 291, 299-300 (2004)
(noting that "some commentators have suggested that the [then-existing] rules might make
some companies reluctant to permit their employees to review patents").
78. See In re Seagate Tech., LLC, 497 F.3d 1360, 1371 (Fed. Cir. 2007) (en
banc). But see Global-Tech Appliances, Inc. v. SEB S.A., 131 S. Ct. 2060, 2069 (2011)
(holding that "willful blindness" to the existence of a patent can satisfy the state of mind
requirement for inducement liability under 35 U.S.C. § 271 (b) (2006)).
79. More precisely, as one moves along the x-axis, the information remains
relevant in the Federal Rules of Evidence context, see supra note 66, but its relevance
diminishes or the information becomes increasingly cumulative.
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and with respect to which she has a cost advantage over the examiner; the y-axis
denotes some unit of value. Curve Us illustrates the social utility of disclosure.
Initially, the disclosure of additional units of relevant information increases Us, but
the marginal social benefits of disclosure outpace the marginal social costs only up
to Q*; as additional units of information are disclosed, social utility declines as the
marginal costs begin to outweigh the benefits.81 From the applicant's private
perspective, however, disclosure makes sense as long as the marginal benefits to
the applicant 82 outweigh the applicant's marginal costs. The applicant therefore
will disclose up to Q**, the point at which the applicant's utility from disclosure
(UApp) is at a maximum (i.e., the surplus of private benefits over private costs is at
a maximum). The region in between Q* and Q** denotes information the disclosure
of which maximizes the applicant's expected private utility but detracts from
social utility; its disclosure, in other words, is socially inefficient. Ideally, the
inequitable conduct doctrine would reduce the difference between Q* and Q** to
zero by aligning the private and social costs and benefits of disclosure.83 Put
another way, the goal of the inequitable conduct doctrine would be to ensure that
dUs/dQ = 0. (3)
As with the cost comparison approach above, however, it is probably not
feasible to attempt to estimate the relevant variable (here, dUs/dQ). The analysis
nevertheless suggests a way of thinking about the relevant policy issue that
underlies the inequitable conduct doctrine; it also further illustrates the gap
between the policy ideal and what may be practically attainable.
80. Alternatively, one could consider the social utility attributable to the
disclosure of information whether the applicant is initially aware of the information or not;
this would enable modeling of a duty to search. As discussed above, however, the
imposition of such a duty appears to me to be an unlikely development. But see Doug
Lichtman & Mark A. Lemley, Rethinking Patent Law's Presumption of Validity, 60 STAN.
L. REv. 45, 61-62 (2007) (proposing a voluntary, supplementary review process that would
allow applicants to submit their own prior art searches in return for a stronger presumption
of validity).
81. These costs include both the private cost to the applicant and any cost
incurred by the examiner or third parties in processing the additional information. As noted
above, however, one recent study casts doubt on the proposition that examiners are
suffering from the effects of "information overload"; on average, they appear not to devote
substantial attention to applicant-submitted prior art even when there is reason to believe it
may be relevant. See Cotropia et al., supra note 58.
82. These marginal benefits include whatever additional revenue the applicant is
likely to derive from disclosure, as modeled in the text above.
83. Much of the criticism of pre-Therasense inequitable conduct doctrine was





B. Modeling an Applicant's Incentive to Disclose
From a more pragmatic perspective, in deciding whether to reveal a
discrete unit of information I at t1, Applicant will consider her expected return
from patenting if she discloses I versus her expected return if she does not. A
rational applicant's decisionmaking process will depend on several
considerations.84 One set of factors to consider is Applicant's subjective
probability that the existence of I affects the validity of one or more of Applicant's
desired claims, as well as the probability that Applicant's nondisclosure of I
amounts to inequitable conduct under the governing legal standard. More
precisely, we can define P(A) as Applicant's subjective probability that I, if
disclosed or discovered, would affect the validity of one or more of her desired
claims (and thus P(Not-A) = 1 - P(A) = Applicant's subjective probability that I
would not affect the validity of any of her desired claims), and P(B) as Applicant's
subjective probability that her failure to disclose I, if such failure were discovered,
would constitute inequitable conduct (and thus P(Not-B) = I - P(B) = Applicant's
subjective probability that the failure to disclose I would not constitute inequitable
84. In reality, the lawyers and agents that draft patent applications may not
consciously take all of the variables discussed above into account in deciding whether to
disclose a given piece of information to the USPTO; they may rely on "best practices"
concerning types of information to disclose rather than making individualized judgments
about each and every I (though individual judgment may be brought to bear with respect to
whether to provide less commonly encountered types of references). Nevertheless, one
would expect agents' decisions at least implicitly to reflect their understanding of the
consequences, as modeled above, of disclosing or not disclosing certain individual
references or categories of references, and to adjust over time with changes in the governing
case law. I thank Dennis Crouch and John Golden for bringing this point to my attention.
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conduct).8 5 (Recall from Part I above that, both pre- and post-Therasense,
information sometimes may be material but non-invalidating.) Figure 2 illustrates
the relationships between these variables-though not necessarily the relative size
of each set, which can vary depending on the applicable legal standards.
Figure 2
y'[(A n B) + (A n Not - B) + (B flNot - A) + (Not- A fl Not - B)] = 1
Applicant's decisionmaking process also must take into account,
however, the probabilities that, if she does not disclose 1, a third party (the
examiner, an accused infringer, a potential licensee, or some other interested third
party) subsequently will discover (1) I's existence, and (2) Applicant's intentional
nondisclosure of L Formally, we can define P(d9 as Applicant's subjective
probability that a third party will subsequently (i.e., at time t1 +,) discover I's
existence, and P(dND) as Applicant's subjective probability that a third party
subsequently will discover that Applicant intentionally failed to disclose 1.86
Applicant then can estimate the present value of revenue R, net of costs, to be
gained under each possible combination of P(A), P(B), P(d), and P(dND).87 For
85. P(Not-A n Not-B) = P(Not-A) x P(Not-BlNot-A) therefore is Applicant's
subjective probability that I does not affect validity and that the failure to disclose I does not
constitute inequitable conduct. P(Not-A n B) = P(Not-A) x P(BINot-A) is Applicant's
subjective probability that I does not affect validity but that the failure to disclose I
constitutes inequitable conduct. P(A n Not-B) = P(A) x P(Not-BIA) is Applicant's subjective
probability that I affects validity but that failure to disclose I does not constitute inequitable
conduct.
86. Conceivably, P(dF) could be related to the amount of information disclosed.
That is, if Q** in Figure 1 exceeds some critical value, perhaps P(dE) goes down due to
some sort of "needle in a haystack" effect. See infra note 91. If examiners typically pay
little attention to applicant-submitted prior art, however, regardless of its quantity or quality,
this effect may be minimal.
87. With four variables to consider, the various combinations cannot be
illustrated in a two-dimensional Venn diagram as in Figure 2 above.
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present purposes, let us assume that Applicant expects to earn R, if either of the
following two conditions is satisfied:
(1) 1 ultimately has no impact on the validity of any of Applicant's
desired claims, and either
(a) Applicant discloses I, or
(b) Applicant intentionally does not disclose I, but this does not
result in a finding of unenforceability because
(i) the failure to disclose I is held not to constitute
inequitable conduct, or
(ii) Applicant's intentional nondisclosure of I is not
discovered.
(2) 1 ultimately would have affected the validity of one or more of
Applicant's desired claims, but Applicant intentionally does not disclose I and no
third party ever discovers I's existence (or, a fortiori, Applicant's intentional
nondisclosure of]).
Assume further that Applicant expects to earn R2 (<R,) if either of the
following two conditions is satisfied:
(1) Applicant voluntarily discloses I and I ultimately does affect the
validity of one or more of her desired claims; or
(2) Applicant intentionally fails to disclose I; a third party subsequently
discovers I's existence, and I ultimately affects the validity of one or more of
Applicant's desired claims; but Applicant's failure to disclose I does not result in a
finding of inequitable conduct, either because the third party does not discover that
Applicant intentionally failed to disclose I or because a court concludes that
Applicant's conduct did not qualify as such.
Note that R2 may be zero if the patent is wholly invalid,
88 but it may be
greater than zero if I does not affect all of Applicant's claims.
Finally, assume that Applicant expects to earn R3 if she intentionally fails
to disclose I; a third party subsequently discovers I's existence and Applicant's
intentional failure to disclose; and the failure to disclose I ultimately results in a
finding of inequitable conduct. Although R3 = 0 under current law,8
9 it could be
greater than zero under some of the proposed reforms. The universe of possible
outcomes can then be summarized as follows:
88. Strictly speaking, R2 can be greater than zero even if the patent is wholly
invalid, if Applicant earns some revenue from its exploitation prior to its being declared
invalid.
89. As with invalidity, R3 could be greater than zero if Applicant earns some
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Note that Applicant's intentional failure to disclose I cannot be discovered unless
I's existence is discovered (dND is a subset of dE, in other words), so (Not-dF) n
dND is an empty set.
Next, let us define FD as the cost (legal fees) of prosecution and
enforcement, net of the cost of disclosure (CAp), if Applicant discloses I; and FD
as Applicant's expected cost of prosecuting and enforcing the patent if she does
not disclose. 90 One would expect FD to correlate positively with P(A), reflecting an
increased cost of prosecution and enforcement the greater the likelihood that I
raises questions about the patentability of one or more claims. Similarly, one
would expect END to correlate positively with P(A), P(B), dE, and dND, reflecting an
increased cost of prosecution and enforcement the greater (1) Applicant's
subjective probability that I will be detected and will raise problems with respect
to validity; and (2) Applicant's failure to disclose I will be detected and will raise
problems with respect to enforceability.
We are now ready to state Applicant's expected revenue if she discloses
and if she does not. If Applicant discloses, her expected revenue E(R)D is
E(R)D = RIP(Not-A) + R2P(A) - CApp - FD. (4)
The intuition is straightforward. Applicant expects to receive R, if I does
not invalidate any claims and R2 if it does.
91 The direct cost of disclosure (e.g.,
drafting an IDS) is CApp, and Applicant's expected legal fees (not including the
direct costs of disclosure) are FD.
If Applicant does not disclose, then (simplifying terms) Applicant's
expected revenue E(R)ND is
E(R)ND = RIP(Not-A nl Not-B nl dE) + RIP(Not-A n B nl dE n Not-dND) +
R 1P(Not-dF) + R2P(A n Not-B n dF) + R2P(A fn B n dE n Not-dND) + R 3P(B n dE n
dND) - FND. (5)
A rational, risk-neutral Applicant therefore will choose disclosure over
nondisclosure whenever Expression (4) is greater than Expression (5), that is,
whenever (after combining terms)
90. To the extent a finding of inequitable conduct risks rendering other, related
patents unenforceable, see supra note 54, and puts the patentee at some risk of having to
pay the defendant's attorney's fees, see supra note 53, these potential costs would be
subsumed within FND.
91. The analysis therefore elides the possibility that Applicant could disclose I in
such a manner that would still leave open the possibility of a finding of inequitable conduct
by, for example, indiscriminately disclosing I among thousands of other pieces of
information. The trend in the case law has been away from holding indiscriminate
disclosure to constitute inequitable conduct. See Molins PLC v. Textron, Inc., 48 F.3d 1172,
1182-84 (Fed. Cir. 1995). But see Feldman, supra note 2, at 15 & n.55 (noting the
possibility that excessive disclosure could subject the patent attorney "to discipline for
breach of ethics" under 37 C.F.R. § 11.18(b)). To the extent this remains a possibility,
however, the analysis above should be understood as assuming that Applicant has engaged
in meaningful disclosure.
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RIP(Not-A n B n dEfn dND) + R2P(A n B n dEfn dND) + (FND- CApp - FD)
> (RI - R9P(A n Not-d) + R 3P(B n dE n dArD). (6)
and
E(R)D = RIP(Not-A) + R2P(A) - CApp - FD > 0. (7)
This last condition is necessary because if the cost of proceeding with the
application is too high, Applicant's preferred strategy is to abandon the application
(and not reveal 1) even if E(R)D> E(R)ND. Note that, in Expression (6), (FND - CApp
- FD) is Applicant's net expected cost saving attributable to disclosure. It could be
either positive or negative, depending on the magnitude of CApP and the difference
between Applicant's expected legal fees net of CApp when she discloses versus
when. she does not. In the limiting case in which P(dF) = 0 (that is, Applicant
believes that I would never be discovered unless she disclosed it), the first two
terms on the left-hand side are zero and the third term is negative because FND <
FD. Because R, > R2, the right-hand term (RI - R 2)P(A n Not-d) must be > 0, and
thus a purely self-interested applicant would never voluntarily disclose under these
circumstances.
C. Modeling Materiality, Intent, and Balancing
The values of P(B) and P(Not-B) in the expressions above will depend on
Applicant's understanding of the standard for a finding of inequitable conduct.
Under current law, as noted above, a finding of inequitable conduct depends on
three factors-materiality, intent, and balancing-which can be modeled as
follows. First, using Expression (1) above, we can define I as material if
PExam[1 E S] x. (1)
In other words, I is material if the probability that the relevant examiner
would conclude that I falls within set S is greater than or equal to some value x. As
suggested above, however, the meaning of this expression will vary depending on
the identity of the relevant examiner, the content of set S, and the value of x. In
theory, PExam could stand for the probability from the standpoint of the actual
examiner assigned to the application, or from the standpoint of a hypothetical
"reasonable" examiner, or from the standpoint of an ideal examiner who perfectly
applies the law to the facts.92 Moreover, in theory PE could be determined at
different time periods, including not only t, (the date of application) but
alternatively t2 (the date of issuance) or t3 (the date of judgment)-or perhaps even
some other time, such as the date Applicant offers a license or the date on which
infringement begins. 93 In addition, S can be defined to include any or all of the
following subsets of information:
92. As noted above, the Therasense opinion does not clearly indicate whether
the new materiality standard defines the relevant examiner as the actual examiner or the
ideal examiner. Therasense does clearly reject prior case law's focus on the hypothetical
reasonable examiner, however. See supra notes 33-34 and accompanying text.
93. Some of the reforms proposed prior to Therasense would have conditioned
a finding of inequitable conduct upon at least one claim being held invalid in litigation, on
the basis of information the applicant intentionally withheld from the USPTO. See supra
note 10 (discussing Patent Reform Act proposals); see also McElhone, supra note 2, at
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Subset 1. Information of such a nature that, if Applicant did not disclose it
and the patent nevertheless issued at t2, one or more claims would be invalid; but if
Applicant did disclose the information, Applicant would still obtain 94 a patent of
the desired claim scope at t2 . Examples would be disclosures necessary to satisfy
Patent Act § 112 and disclosures of the names of co-inventors.
Subset 2. Information that would preclude Applicant from obtaining a
patent of the desired claim scope, but not necessarily from obtaining a patent of
narrower scope. Examples would be information that either solely or in
combination with other information demonstrates (at least until rebutted) that one
or more of the Applicant's desired claims lack novelty or are obvious.
Subset 3. Information that some other rule of patent law requires the
Applicant to disclose truthfully, but that is not of a type that would lead to
invalidation if not disclosed. Examples would include information relating to small
entity status or to the Applicant's entitlement to a petition to make special.
Subset 4. Information the disclosure of which might lead to the discovery
of information falling into one of the other categories. Subset 4 could be further
broken down into smaller subsets-for example, information that would
necessarily lead to the discovery of information falling into Subset 1 only, or
information that would not necessarily lead to the discovery of information falling
into one of the other subsets but rather would only increase the probability of the
discovery of such information by some amount q.
Finally, the value of x in Expression (1) depends on how strict the
materiality requirement is. In theory, x could fall anywhere along the spectrum of
407-08; Brown, supra note 2, at 618 (discussing testimony presented at Patent Reform Act
hearings in support of such a but-for rule). This proposal in effect would adopt the relevant
time period as t3. The proposal differs from the standard adopted in Therasense, in which
the majority posited the possibility that information the applicant withheld could have made
a difference to the examiner under the preponderance of the evidence standard or under the
"broadest reasonable construction" canon that applies to the construction of patent claims
during examination-and thus would be material-but would not lead to patent invalidation
under the corresponding evidentiary standards that apply during litigation. See Therasense,
Inc. v. Becton, Dickinson & Co., Nos. 2008-1511, -1512, -1513, -1514, -1595, 2011 WL
2028255, at *11 (Fed. Cir. May 25, 2011) (en banc).
94. Depending on the identity of the relevant examiner, "would still obtain"
could mean that Applicant would be entitled to a patent of the desired claim scope at t2, or
that Applicant would, in fact, obtain a patent of the desired claim scope at t2. Note that the
actual examiner is not allowed to testify on these matters. U.S. PATENT & TRADEMARK
OFFICE, U.S. DEP'T OF COMMERCE, supra note 55, § 1701.01.
95. In the wake of Therasense, current law would now appear to include at least
Subsets 1 and 2 within S, insofar as this type of information affects patent validity.
Therasense would appear to exclude Subset 3, however, unless the applicant has made
affirmative misrepresentations concerning this sort of information. See supra note 55.
Therasense does not clearly indicate whether or to what extent information falling within
Subset 4 is material under the new standard, though a strict but-for standard might suggest
that information is material only if it necessarily would have led to the discovery of
information falling into Subsets 1 or 2.
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0 < x < 1, though the closer x is to 1 the more likely a consensus would exist that
the information is material.
The differences among the various past, present, and proposed standards
of materiality therefore can be compared as follows:
Table 2
Past, Present, and Proposed Standards of Materiality
Standard Relevant Time when PEis Contents of S x =
examiner determined
Objective but-for Ideal t, Subsets 1, 2; 4? 1
Subjective but-for Actual h Subsets 1, 2; 4? 1
Actual?
"But it may have" Reasonable? 1,2,4
Rule 56, 1977 version Reasonable tj 1,2,3,4 ?
Rule 56, 1992 version Ideal? t, 1,2 1?
Proposed standard under
which no inequitable
conduct unless at least Ideal t3 1,2
one claim is rendered
invalid as a result
Viewed in this format, the differences among the standards-and the
areas with respect to which the value of the relevant variables is uncertain or
ambiguous, as denoted by the question marks in Table 2-become apparent. First,
the identity of the relevant examiner varies, not surprisingly, depending on the
standard used. (Indeed, with respect to two of the standards, the case law did not
clearly identify the relevant examiner.) Second, the relevant time frame for all five
of the pre-Therasense standards would appear to be ti. By contrast, with respect to
a proposed standard under which a finding of inequitable conduct is contingent on
the invalidity of at least one claim, the relevant time frame is arguably t3, the date
of judgment. Third, the content of the relevant information set varies depending on
the test employed, though once again the precise content is unclear with respect to
at least two of the standards. Fourth, and perhaps most significantly, x is
presumably some amount less than 1 under the but-it-may-have and reasonable
examiner standards (and maybe under the 1992 version of Rule 56); just how
much less, however, is unclear. Given these uncertainties, the fact that the
decisions on inequitable conduct struck many observers as inconsistent is not
surprising.
As for the second relevant factor, we can define Applicant as having the
requisite deceptive intent if
PApp [I E S] >Y. (8)
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that is, if Applicant's subjective probability at t, that the information falls within
set S is greater than some value y. Put another way, does Applicant believe at t,
that I may be material, and if so, how strongly does Applicant believe this?
96
On this analysis, an applicant who is not aware of the information would
(as under current law) lack deceptive intent altogether. Similarly, an applicant who
is aware of the information but who does not grasp its significance also would (as
under current law) lack deceptive intent, even if the applicant's failure to grasp its
significance can be characterized as simple or gross negligence. Presumably, then,
y must be substantially higher than zero. How high it must be nevertheless remains
unclear, even post-Therasense. Must it be close to 1? Only greater than 0.5?
Further compounding this uncertainty is the question of how an accused infringer
may go about proving that y exceeds the relevant threshold. As noted in Part I, the
extent to which materiality can serve as circumstantial evidence of intent remains
somewhat unclear post-Therasense; further, pre-Therasense, some cases held that
an inference of deceptive intent was appropriate if I was highly material, the
applicant knew or should have known of its materiality, and the applicant could
not offer a convincing explanation for withholding the information. 97 From a
purely evidentiary standpoint, using materiality as an indicium of intent might not
seem problematic; all other things being equal, the information's actual materiality
is likely to correlate to some degree greater than zero with the applicant's
subjective belief as to its materiality. As discussed above, however, critics
contended that the now-discarded "should have known" standard tended to
conflate intent with materiality and permitted an inference of intent on the basis of
96. By focusing on the applicant's state of mind, rather than on the state of mind
of the examiner or some hypothetical entity, Expression (8) distinguishes deceptive intent
from materiality as modeled in Expression (1). Perhaps a more complete definition of
deceptive intent would be PApp[PExa,[I c S] > x] > y, meaning that Applicant has deceptive
intent if she believes that the probability is greater than or equal to y that the probability the
relevant examiner would find I to fall within S is greater than or equal to x. This would
reflect a possible feedback effect between materiality and intent, but it would also make an
already complex analysis yet more complex without necessarily adding much to the model's
predictive value. Note also that, if S is defined to include, say, only Subsets I and 2, an
intent to deceive as to one's small entity status (for example), though deceptive, would not
count as deceptive intent for purposes of the inequitable conduct doctrine.
At least one commentator has argued that deceptive intent should incorporate another
factor-specifically, that no deceptive intent should be found where the examiner should
have discovered the information at issue by following the examination protocols set forth in
the Manual of Patent Examining Procedure. See Brief of Amicus Curiae Dolby Labs., Inc.
in Support of Neither Party at 6, Therasense, 2011 WL 2028255 (Nos. 2008-1511, -1512,
-1513, -1514, -1595), 2010 WL 2861896, at *6. The analysis above avoids this additional
complicating factor; if added, however, Expression (10) could be revised to state (PAp[I E
s]) > y n (PAPP(d.) > y ')), where y' presumably would be at or near 1. See also Petherbridge
et al., supra note 2, at 47-48, 53-54 (discussing various ways of characterizing intent, and
suggesting that, pre-Therasense, what counted as deceptive intent for purposes of the
inequitable conduct doctrine might be a more fluid concept).
97. See supra text accompanying note 42.
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mere negligence. 98 The analysis above arguably provides some support for this
view. One way of thinking about the "should have known" standard is that it
substituted a hypothetical, reasonable applicant's estimate of the probability of
materiality for the actual applicant's subjective estimate of the probability of
materiality-in much the same way that the reasonable examiner standard
substituted a hypothetical reasonable examiner's probability estimate for the actual
examiner's estimate. To the extent a hypothetical reasonable examiner and a
hypothetical reasonable applicant are likely to have similar probability estimates,
therefore, critics may have been right in arguing that the "should have known"
standard conflated intent with (a high degree of) materiality, at least where
materiality was determined under the reasonable examiner standard.
The third relevant factor-balancing-means that even if the threshold
levels of materiality and intent are present, the court must balance the equities to
determine if a finding of inequitable conduct is appropriate. 99 Mathematically,
then, one might represent the three requirements for inequitable conduct in the
following manner. Inequitable conduct is present if:
P~xam [1 IE S] _X, (1)
PAPp [1 e S] y, (8)
and
at(x, y) > z, (9)
where a is an operator applied to x and y. Even after Therasense, however, it
remains unclear exactly what that operator is (addition? multiplication? something
more complex?); similarly unspecified is the requisite value of z.
On the basis of this analysis, we may define P(B) in the following
manner:
P(B) = P [(PExam[I S] >x) fn (PAPP[-I S] y) fn (a (x, y) > z)],
(10)
where P* equals Applicant's subjective probability at time t, that a court at time t3
would view the three conditions set forth in Expressions (1), (8), and (9) as
satisfied.
III. IMPLICATIONS OF THE PRECEDING ANALYSIS
Scholarly discussion of the inequitable conduct doctrine to date has
centered on aspects of the doctrine that critics viewed as dysfunctional-among
them, the multiplicity and inconsistency of the relevant standards for determining
materiality and intent; the resulting compliance and adjudication costs; and the
98. See supra text accompanying note 43. Another related critique might be that
the focus on the applicant's inability to offer a convincing explanation conflicted with the
requirement that intent (and materiality) be proven by clear and convincing evidence.
99. See supra text accompanying note 50. Furthermore, as noted above, prior to
Therasense, the Federal Circuit had approved the use of a sliding scale under which a higher
degree of materiality could compensate for a lesser, but still above-the-threshold, degree of
intent and vice versa. See supra text accompanying note 44.
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perceived disconnect, in some cases, between the gravity of the offense and
resulting penalty.' 00 As noted above, Therasense resolves some but not all of these
issues (and may not, in any event, be the last word on the contours of the doctrine,
given the possibility of further refinements on the part of Congress or the Supreme
Court). The debate is therefore likely to continue, and it would benefit from
additional efforts, both to ground the doctrine in a deeper theoretical framework
and to subject its real-world impact to rigorous empirical analysis. 10 1 This Article
has attempted to advance matters on the theoretical front by restating, with as
much precision as possible, both the conditions under which the doctrine would
promote the public interest and the factors that would influence a rational applicant
in deciding how much information to disclose. This Part discusses the implications
of the theoretical analysis presented above. In particular, it highlights the imperfect
nature of the inequitable conduct doctrine as a means for inducing optimal
disclosure, and it provides some basis for predicting the effects (alone or in
combination) of various actual or proposed reforms. Although some of the
predictions are obvious (e.g., narrowing the definitions of materiality or intent will
reduce disclosure), the interactions among the relevant variables are not. By
disaggregating the forces that lead to the predicted results, future policymakers
may consider the impacts of modifying one or more of the relevant policy levers,
as well as the ways in which other possible reforms may increase or decrease the
effect of, or need for, a robust inequitable conduct doctrine.
A. The Gap Between Theory and Practice
Perhaps the most striking implication of the theoretical analysis presented
above is the gap between the inequitable conduct doctrine (even post-Therasense)
and the proposed underlying purpose of inducing optimal disclosure. Part II
proposed that the ideal inequitable conduct standard would induce disclosure
when:
PExam[I E S] _x, (1)
CApp < CExam (2)
and
dUs/dQ = 0. (3)
As suggested, however, while it might be tempting to consider simply
adopting these criteria themselves as the conditions under which a failure to
disclose constitutes inequitable conduct, attempts to measure dUs/dQ or to
compare CA,, with CExam are probably impracticable. At best, then, the inequitable
conduct doctrine can provide only a rough proxy for these ideal conditions;
although Expression (1) embodies some version of a materiality standard, neither
of the other conditions shares any obvious connection with the deceptive intent
element or with balancing.
100. See supra notes 56-63 and accompanying text.
101. Two recent empirical studies of note are Cotropia et al., supra note 58
(examining examiner behavior), and Petherbridge et al., supra note 2 (examining courts'
application of the doctrine).
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A second implication arises from Part II's analysis of the factors that
would induce a rational, risk-neutral applicant to choose disclosure over
nondisclosure. As above, those conditions are:
RIP(Not-A n B n dEndND)+ R2P(A BdEndND) 
+ 
(FND- CA - FD) >
(R1 - RJ)P(A f Not-dF) + R3P(B f dE f dND) (6)
and
E(R)D = R P(Not-A) + R2P(A) - CA - FD > 0, (7)
where
P(B) = P*[(PExam[I s] > x) n (PAPP [I E S] > y) n (a (x, y) _z)].
(10)
As we have seen, many of these variables are either inherently difficult to
estimate (for example, FND) or poorly defined (for example, just about everything
that goes into P(B)).10 2 Whether current law comes close to inducing disclosure to
the extent that it would occur under ideal conditions (1), (2), and (3) is, therefore,
doubly indeterminate. Conceivably, the existing standards could induce departures
from the ideal in either direction (i.e., too much or too little disclosure, in
comparison with the ideal), depending on the case. In some other areas of the law,
such as antitrust, a method of dealing with analogous risks of error involves
crafting standards that attempt to minimize the total cost of "false positives"
(wrongly finding violations where none exist), "false negatives" (wrongly
exonerating violative conduct), and enforcement and other administrative costs. 
103
The cost of false positives and false negatives, in turn, is a function of both their
frequency and magnitude. 10 4 How might such an approach play out in the context
of the inequitable conduct doctrine?
On the one hand, one might argue that the cost of false negatives should
be of greater concern than the cost of false positives, on the theory that more
information is generally better than less. All other things being equal, a broad (that
is, relatively defendant-friendly) standard of inequitable conduct should induce
more disclosure of information that might relate to patentability (or otherwise
implicate the integrity of the patent system); in turn, the disclosure of such
information may help to weed out invalid claims that otherwise would have evaded
successful challenge. Moreover, one might argue, applicants can avoid the cost of
false positives simply by following a policy of "when in doubt, disclose."'1 5 On
102. Therasense resolves some, but not all, of the ambiguity with respect to these
variables. See supra notes 32-49 and accompanying text.
103. See, e.g., Thomas F. Cotter, The Procompetitive Interest in Intellectual
Property Law, 48 WM. & MARY L. REV. 483, 490-91 & n.17 (2006) (discussing the use of
error-costs analysis in antitrust and intellectual property law).
104. See id. at 493 n.24, 526.
105. See Therasense, Inc. v. Becton, Dickinson & Co., 593 F.3d 1289, 1305 (Fed.
Cir. 2010) ("[I]f this could be regarded as a close case, which it is not, we have repeatedly
emphasized that the duty of disclosure requires that the material in question be submitted to
the examiner rather than withheld by the applicant."), vacated and reh "g en banc granted,
374 F. App'x 35 (Fed. Cir. 2010) (per curiam). Further, the consequences of a false negative
surely could be present in some cases-for example, when the misconduct would not come
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this view, efforts to weaken the inequitable conduct doctrine will lead to less
disclosure and more fraud, to the detriment of the public. (Note, however, that the
magnitude of the harm resulting from a false negative will be mitigated if P(d)
and P(dND) are sufficiently high or Ca is sufficiently low. If, on the other hand,
P(dE) and P(dD) are low 10 6 or CExam is high, the cost of a false negative will be
relatively higher.)
The problem with this view is that it ignores the cost of both false
positives and enforcement. As for false positives, it may be true that the private
cost of disclosing one additional piece of information in an IDS is small; but the
cost of disclosing hundreds of references in order to avoid a false positive may add
up significantly. To be sure, the disclosure burden that the inequitable conduct
doctrine imposes may not price many applicants out of the market, but at the
margin there is some risk that, in terms of Expression (6), if CAp is too high
E(R)D < 0 and the applicant's better strategy is abandoning the application.' 07 More
is not always better, particularly if the disclosed information is of little social
value. 10 8 In short, the threat of false positives encourages over-compliance with
patent law's disclosure requirements, in ways that may (at times) be at best
pointless and at worse counterproductive-though whether, either pre- or post-
Therasense, those costs generally outweigh the costs of false negatives cannot be
determined by theory alone.
As for enforcement costs, it seems clear that the easier it is to plead
inequitable conduct, and the more complex the legal standards themselves are, the
higher these costs will be. These costs may be borne in a number of ways. To the
extent the examiner must wade through numerous references of marginal
relevance, the already-backlogged patent examination system risks incurring
additional delays. To the extent the examiner ignores all or most of the references,
the cost of processing them is merely deferred to the time, if any, at which the
patent is litigated. At that point, an expansive inequitable conduct doctrine raises
the (already quite high) costs of patent litigation, not only because of the doctrine's
to light otherwise because the defendant would not have had an incentive to raise the issue
otherwise. Moreover, patentees who have failed to disclose may be able to extract
unwarranted rents from risk-averse licensees. See Cotropia, supra note 2, at 751-52.
106. See Long, supra note 12, at 669 (suggesting that applicants may choose to
conceal information they do not expect others to uncover).
107. Moreover, too much indiscriminate disclosure may actually impede others'
ability to process the disclosed information in any meaningful way, see Cotropia, supra note
2, at 773, though the empirical evidence on this point is not strong, see Cotropia et al., supra
note 58.
To be sure, the fewer patents there are, the smaller the risk of the associated social
costs of patenting, including occasional monopolistic pricing. The same could be said for
the inequitable conduct doctrine as applied in litigation. Even when a court incorrectly
determines that a patentee engaged in inequitable conduct, the social cost of the false
positive is not entirely a "cost" because the public gains free access to the invention. Taken
to its logical conclusion, however, this reasoning would undermine the whole point of
having a patent system. Put another way, this reasoning ignores the potential dynamic
efficiency costs from arbitrarily undercutting the patent incentive, encouraging inventors to
rely more heavily on trade secret protection over patent protection, and so on.
108. See Cotropia, supra note 2, at 770-73.
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complexity but also because of the additional discovery burden imposed on the
patentee. 1°9 The system therefore risks imposing a vicious circle. Insofar as the
higher FND is in Expression (6) above, the more the prudent applicant will choose
to disclose, all other things being equal, and the more she discloses, the higher the
ensuing litigation costs. At the margin, a feedback loop1 10 may come into existence
as more and more disclosure is seen as routine, thus influencing courts' and
parties' expectations of the data that reasonably should be viewed as falling within
S. Whether Therasense adequately addresses this problem, by virtue of its adoption
of some version of a but-for standard of materiality, remains to be seen.
B. Predicting the Effects of Various Proposed Reforms
Many of the reform proposals put forward in recent years rest upon the
premise that pre-Therasense law generally induced applicants to overdisclose
information of only marginal relevance.'' The analysis presented in Part II
provides a tool for predicting the effects of various reform proposals in countering
this purported effect. It also may assist in imagining other possible reforms, and in
predicting the effects on disclosure of proposals intended to reform other aspects
of the patent system.
1. Some Commonly Suggested Reforms
As stated above, a rational, risk-neutral applicant would prefer disclosure
to nondisclosure if disclosure promises a positive return, and if
RIP(Not-A n B n dEfn dND) + R2P(A n B n dEfN dND) + (FND- CApp - FD) >
(RI - R2)P(A n Not-dE) + R3P(B n d fN dND). (6)
We can also use Expression (6) to consider some of the reforms that
critics of existing doctrine have proposed. One set of reform proposals would aim
109. For example, the attorney who drafted the application is typically deposed.
Attorney-client privilege issues often arise. Satellite litigation over inequitable conduct can
become a serious problem. See Cotropia, supra note 2, at 740. But see Jason Rantanen &
Lee Petherbridge, Therasense v. Becton Dickinson: A First Impression 18 n.29 (June 17,
2011) (unpublished manuscript) (on file with Arizona Law Review) (questioning the impact
of the doctrine on discovery costs). As for the expense of patent litigation, see AM.
INTELLECTUAL PROP. LAW Ass'N, 2009 REPORT OF THE ECONOMIC SURVEY 29 (2009)
(reporting median litigation costs of $650,000 to $5.5 million, depending on the amount at
risk). Rantanen and Petherbridge also argue that, post-Therasense, the but-for standard
could prove more costly than the reasonable examiner standard, due both to possible
complexities in the but-for standard's application, and to a potential increase in defendant's
proclivity to resist assertions of patent rights if the new standard results in the issuance of
more patents of dubious value and/or an increase in unacceptable conduct on the part of
patent owners. See Rantanen & Petherbridge, supra, at 15-19. Time will tell.
t0. Cf James Gibson, Risk Aversion and Rights Accretion in Intellectual
Property Law, 116 YALE L.J. 882, 898-900 (2007) (arguing that risk-averse users' decisions
to license rather than to assert fair use rights creates a similar sort of feedback effect). In the
case of inequitable conduct, a feedback loop might result from courts coming to expect
more disclosure, and hence being more apt to find omissions both material and intentionally
deceptive.
Ill. See supra notes 58-59 and accompanying text.
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to reduce P(B) by, for example, adopting a relatively narrow definition of
materiality1 2 or deceptive intent;1" 3 or by clarifying (or eliminating) the balancing
inquiry modeled above in Expression (9).114 (Therasense succeeds in narrowing
the definitions of materiality and deceptive intent, though as noted above several
ambiguities remain; and the opinion does not eliminate the balancing inquiry.) All
other things being equal, a reduction in P(B) reduces the three terms on the left-
hand side of Expression (6) while leaving the first term on the right-hand side
unchanged. A predictable and intended result of reducing P(B), therefore, would
be to reduce disclosure on the part of the applicant. To illustrate, consider the
proposal to condition a finding of inequitable conduct upon a finding at t3 that I
renders one or more claims invalid.1 5 Pre-Therasense, the case law disclosed
several instances in which information that the patentee withheld did not affect
patentability but nevertheless did result in a finding of inequitable conduct."' In
terms of the analysis above, this reform (as row 6 of Table 2 indicates) would, in
effect, adopt an "ideal examiner" standard of materiality (because the court would
be asking whether I should have affected claim validity from the court's own
perspective as of t3); would limit S to Subsets 1 and 2;
1 17 and would equate x with
1. As a result, P(B) would be on average lower than under pre-Therasense law,
where S may have included all four subsets and the value of x was indeterminate;
and FND would be lower as well, reflecting a smaller expected litigation cost from
nondisclosure. (The marginal decrease in uncertainty would also ameliorate risk
aversion to some extent, as discussed in Part III.B.2 below.) In addition, because
P(Not-A fn B) would be zero, the R, term on the left-hand side would equal zero
112. See Dolak, supra note 2, at 887-88 (arguing that material misconduct should
be defined as acts that "undermine the substantive examination function of the USPTO");
Mammen, supra note 2, at 1391 (arguing for adoption of the 1992 materiality standard).
113. See Cotropia, supra note 2, at 775-77 (arguing in favor of "a specific,
independent standard for intent"); Dolak, supra note 2, at 888-90 (arguing that courts
should apply a more rigorous definition of intent); Mammen, supra note 2, at 1391-92
(similar).
114. See Dolak, supra note 2, at 890-91 (arguing that courts should abandon the
balancing inquiry because "it exacerbates the problem of lax application of the intent
standard"); Mammen, supra note 2, at 1391 (arguing for clarifying and codifying the
balancing requirement).
115. See supra note 93 (discussing how this proposal differs from the rule adopted
in Therasense).
116. See, e.g., Avid Identification Sys., Inc. v. Crystal Imp. Corp., 603 F.3d 967,
973 (Fed. Cir. 2010) (affirming judgment of unenforceability due to inequitable conduct,
where company president failed to disclose a trade show demonstration that, "while not
invalidating, reflected the closest prior art, and thus was highly material to patentability");
Nilssen v. Osram Sylvania, Inc., 504 F.3d 1223, 1235 (Fed. Cir. 2007) (affirming judgment
of unenforceability due to inequitable conduct; district court and court of appeals did not
address validity); McKesson Info. Solutions, Inc. v. Bridge Med., Inc., 487 F.3d 897, 926
(Fed. Cir. 2007) (affirming judgment of unenforceability of the '716 patent due to
inequitable conduct; district court and court of appeals did not address validity); Cargill,
Inc. v. Canbra Foods, Ltd., 476 F.3d 1359, 1371-72 (Fed. Cir. 2007) (affirming judgment of
unenforceability of the '169 and '145 patents due to inequitable conduct; district court and
court of appeals did not address the validity of these two patents).
117. And, possibly, some portion of Subset 4. See supra note 95.
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and the left-hand R2 term also would decrease. As expected, then, the proposal
would reduce the amount of disclosure-perhaps significantly, because of the
multiple consequences for the left-hand side.
To be sure, the model cannot predict the amount by which a reduction in
P(B) would decrease aggregate disclosure. Moreover, even if pre-Therasense law
resulted in systematic overdisclosure, at some point further reductions in P(B) (for
example, eliminating the doctrine altogether, such that P(B) - 0) risk overshooting
the mark (in terms of Figure 1, of moving Q** to the left of Q).118 In the example
above, if the set S were defined too narrowly, applicants might choose to conceal
information falling within Subsets 3 or 4 above, or information the truth that might
have led the examiner to consider the evidence in a different light." 9 It is at least
arguable, however, that the inequitable conduct doctrine need not be invoked in
such circumstances. Opposing counsel who uncovers evidence that, for example,
the applicant misrepresented its small inventor status could instigate disciplinary
proceedings against the offending attorney. 12 Alternatively, one could retain a
118. More precisely, eliminating the inequitable conduct doctrine altogether
would mean, ceteris paribus, that disclosure would occur only when:
(FND - CAp,, - FD) > (R, -R2)P(A n Not-d). (11)
Given that R, > R,, the right-hand term is positive and applicants would disclose only
for sufficiently high values of (FND - CAp - FD). This is not an impossible condition; if
P(d) is sufficiently high, Applicant might conclude that her revenue would be higher if she
disclosed, accepted the resulting consequences, if any, and reduced to some extent the risk
of a potentially costly validity challenge thereafter. For low values of P(dr), however,
Applicant may choose not to disclose L (Recall that as P(d) -+ 0, (FND - CAp - FD) can
become negative. See supra p. 762.) In such a case, the existence of some form of
inequitable conduct doctrine may make the difference between applicant disclosure and
nondisclosure.
119. An example can be drawn from the facts of New Medium, where Judge
Posner concluded that the applicant intentionally failed to disclose an expert's previous
connections with-and thus possible bias in favor of the applicant. See New Medium LLC
v. Barco N.V., 582 F. Supp. 2d 991, 998 (N.D. Ill. 2008) (Posner, J., sitting by designation),
vacated by agreement of parties, No. 05 C 5620, 2009 WL 2385890 (N.D. Ill. May 15,
2009); see also Ferring B.V. v. Barr Labs., Inc., 437 F.3d 1181, 1188 (Fed. Cir. 2006) ("[A]
declarant's past relationships with the applicant are material if (1) the declarant's views on
the underlying issue are material and (2) the past relationship to the applicant was a
significant one."). Whether the truth would have made a difference or not is hard to tell. In
terms of Table 2 above, a materiality standard that requires proof that x = 1 might eliminate
the incentive to disclose information of this type.
120. See Brief& Appendix of the American Bar Ass'n as Amicus Curiae at 17 &
n.6, Therasense, Inc. v. Becton, Dickinson & Co., Nos. 2008-1511, -1512, -1513, -1514,
-1595, 2011 WL 2028255 (Fed. Cir. May 25, 2011) (en banc) (discussing USPTO's power
to sanction patent attorneys); cf Cotropia, supra note 2, at 766 (noting the various ways in
which the failure to comply with the inequitable conduct doctrine can result in disciplinary
action against the offending attorney). One piece of anecdotal evidence suggesting that
opposing counsel would still be motivated to bring such lesser misconduct to the attention
of a court, the USPTO, or another disciplinary authority, as appropriate, can be found in the
context of Rule 11 sanctions. Rule 11 sanctions are generally less consequential than the
penalties for inequitable conduct. See FED. R. Civ. P. 11(c)(4). Under this rule, for example,
sanctions "must be limited to what suffices to deter repetition of the conduct or comparable
conduct by others similarly situated," and "may include nonmonetary directives; an order to
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broad definition of S while reforming the doctrine in other ways-for instance, by
instituting a more nuanced system of penalties as discussed below, or by defining
other P(B)-related variables such as a and x with more precision.
A second set of reform proposals involves modifying the penalty for
inequitable conduct in some manner. Under current law, a finding of inequitable
conduct results in the patent being rendered unenforceable in its entirety; as noted
above, however, some reformers have suggested an administrative penalty alone,
or a range of penalties from which a court could select, based on the seriousness of
the offense. 12 1 In terms of Expression (6), any increase in the value of R3 would
increase the right-hand side of the Expression and thus make disclosure somewhat
less likely, all other considerations being equal; it would also tend to mitigate, to
some extent, any risk aversion 122 arising from uncertainty over the values of B, dE,
and dND. Moreover, to the extent R 3 is tailored to the egregiousness of the
offense-that is, R3 = f(P(B)) and dR3/d(P(B)) < 0-disclosure will decrease
further as P(B) decreases. How much less disclosure will occur depends on the
magnitude of R3, holding everything else constant. At the same time, any such
reform could marginally increase FND and CExam by adding yet another layer of
complexity (selecting the right penalty) to the inequitable conduct doctrine, though
this additional complexity could be mitigated by adopting guidelines along the
lines that some commentators have advocated.
123
A related reform would be to render unenforceable only those claims that
are directly affected by the inequitable conduct. 124 In theory, this reform could still
pay a penalty into court; or... an order directing payment to the movant of part or all of the
reasonable attorney's fees and other expenses directly resulting from the violation." Id As
noted above, inequitable conduct results in unenforceability of the patent, and sometimes
payment of attorney's fees as well. See supra note 53 and accompanying text. Nevertheless,
it appears that attorneys still file Rule 11 motions when the evidence so warrants. While
hardly dispositive, a Westlaw search of (motion /s ("frcp" "fed. r. civ. p." "fed. r. civ. proc."
"federal rule of civil procedure" "federal civil procedure rule") +1 t1) & da(aft 12-31-
2008)) in the allfeds database yields 247 cites at the time of this writing. See also Charles
Yablon, Hindsight, Regret, and Safe Harbors in Rule 11 Litigation, 37 LoY. L.A. L. REV.
599, 614-15 (2004) (presenting results of "quick and dirty empirical research" to the effect
that motions for Rule 1 1 sanctions decreased, as intended, after the 1993 amendment to the
rule, but still appear to number in the hundreds every year).
121. See supra text accompanying notes 60-63.
122. See infra Part III.B.2.
123. See Murphy, supra note 2, at 2296-2302. Both Cotropia and Mammen argue
against allowing courts discretion to choose among a range of penalties, however, on the
ground that such discretion would increase uncertainty, see Cotropia, supra note 2, at 775,
or encourage weak assertions of the defense, see Mammen, supra note 2, at 1392-93.
124. See Cotropia, supra note 2, at 775; Mammen, supra note 2, at 1392. If
information is material only if it would have affected patent validity at t 3 this rule would
render the inequitable conduct doctrine moot. See Patent Office Prof I Ass'n, supra note 2,
at 1. If information can be material even though it does not affect validity at t3-- for
example, because a reasonable examiner would have considered it important-inequitable
conduct would still have an independent, though limited, role to play even if only some of
the patent's claims are unenforceable. See Cotropia, supra note 2, at 779; Mammen, supra
note 2, at 1392.
774 ARIZONA LAW REVIEW [VOL. 53:735
allow inequitable conduct to play a role independent of invalidity; 125 a claim might
not be rendered invalid by virtue of I, for example, but if I posed a sufficiently
serious risk of invalidating a particular claim, the applicant's failure to disclose I
could be grounds for rendering that claim (but not the entire patent) unenforceable.
In addition to the reduction in effects resulting from risk aversion that this latter
change would entail, the proposal would increase R 3 and decrease FND; in
combination, these effects would reduce disclosure to some extent, though perhaps
less so than would a substantial reduction in P(B).
2. The Effect of Risk Aversion
Thus far, the analysis has assumed a rational, risk-neutral applicant, but a
more realistic assumption might be that the applicant (or her agent) is to some
degree risk-averse. A risk-averse applicant, "when faced with a choice between
two gambles with the same expected value, will usually choose the one with a
smaller variability of return., 126 In the present context, this means that a risk-
averse applicant will sometimes choose disclosure over nondisclosure even when
E(R)D < E(R)ND--in effect, incurring the cost of a risk premium to avoid some
degree of risk associated with nondisclosure. 127 As a general matter, the greater the
variance associated with E(R)ND, the higher the risk premium a risk-averse
applicant would be willing to incur. In the present context, the effect of risk
aversion may be important for two reasons.
The first is that risk aversion could play a significant role in determining
how much information applicants disclose. To be sure, the applicant may not be
the individual inventor, but rather a corporate assignee and corporations may be
less risk-averse than are individuals. 128 But even if the assignee is not risk-averse,
125. An objective but-for test would negate this possibility, but as noted above, it
remains to be seen whether Therasense adopted such a test.
126. WALTER NICHOLSON, MICROECONoMIc THEORY: BASIC PRINCIPLES AND
EXTENSIONS 538 (9th ed. 2004); see also ROBERT S. PNDYCK & DANIEL L. RUBINFELD,
MICROECONOMICS 158 (5th ed. 2001).
127. Suppose, for example, that E(R)D $100,000 and E(R)ND = $125,000.
Depending on her degree of risk aversion, a risk-averse applicant might prefer E(R)D to
E(R)ND if the variance around the mean associated with nondisclosure is much larger than
the variance associated with disclosure. To use the simplest possible example, if E(R)D were
sure to equal $100,000, whereas E(R)ND were sure to equal $0, 50% of the time, and
$250,000, 50% of the time, a moderately risk-averse applicant might choose the certain
payoff associated with E(R)D to the less certain, though actuarially higher value, payoff
associated with E(R)ND.
128. A common assumption among economists is that individuals tend to be risk-
averse, while institutions tend to be risk-neutral. See, e.g., PINDYCK & RUBINFELD, supra
note 126, at 157; RICHARD A. POSNER, ECONOMIC ANALYSIS OF LAW § 1.2, at 11 (7th ed.
2007). Even so, corporate agents-like the patent attorneys discussed in the text above-
may be risk-averse and, absent effective monitoring, act accordingly (thus imposing an
agency cost on their corporate principals). Whether individual inventors are likely risk-
averse is unclear. See F.M. Scherer, The Innovation Lottery, in EXPANDING THE BOUNDARIES
OF INTELLECTUAL PROPERTY: INNOVATION POLICY FOR THE KNOWLEDGE SOCIETY 3, 19-21
(Rochelle C. Dreyfuss et al. eds., 2001) (discussing the possibility of a "lottery effect,"
whereby some inventors and creators are motivated by the small ex ante probability of
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the individual patent attorney (like individuals generally) may exhibit some degree
of risk aversion. As Professor Cotropia has noted, the consequences for an attorney
accused of inequitable conduct can include reputational harm, disciplinary action,
and opportunity costs associated with having to assist with discovery requests
(including submitting to a deposition). 129 As a result, patent applicants may incur
an agency cost resulting from the disparity between the applicant's and the
attorney's tolerance for risk. To the extent legal services exhibit credence
characteristics, 130 there may be no simple or direct way for applicants to constrain
these costs.
The second is that, to the extent the applicant or her agent is risk-averse,
the uncertainties inherent to the inequitable conduct doctrine may induce the
applicant or her agent to disclose even when the left-hand side of Expression (6) is
smaller than the right-hand side, that is, when
RP(Not-A nl B n dE n dND) + R2P(A n B n dE fl dND) + (FND- CAp - FD) <
(RI - R 2)P(A fl Not-d) + R 3P(B n dE fl duD).
Under current law-arguably even post-Therasense-many of the
considerations that a rational applicant would take into account in deciding
whether to disclose are likely to exhibit high variability. In particular, the value of
P(B), which in turn informs the value of E(R)ND, is dependent on the values of S, x,
y, a, and z, and on the identity of the relevant examiner. As we have seen, none of
these variables was clearly defined pre-Therasense, and some of them remain hazy
even in the wake of that decision. A legal standard that reduces the uncertainty
surrounding P(B)-perhaps by clearly adopting some version of an objective but-
for test and by further clarifying the meaning of the deceptive intent element and
its relation to materiality-would alleviate this problem to some extent (although
substantial uncertainty still might surround other variables such as dE and dVD, and
because it is a function in part of these variables, FND). Of course, the effect of
such a change might also be to reduce the value of P(B) as well, with the results as
predicted in Part III.B.1 above. Further refining the standards for materiality or
intent, in other words, would likely have a compound effect on the applicant's
incentive to disclose by both decreasing the left-hand side of Expression (6) and by
reducing the impact, if any, of applicant risk aversion.
3. Some Less Obvious Reforms
To the extent overdisclosure remains a problem under current law, a less
obvious means for reducing that problem would be to raise CApp such that some
amount of disclosure that Applicant would find cost-effective under current law
earning vast rewards from their creations); Cotter, supra note 103, at 529 n.192 ("In many
institutional settings, however, managers may be more risk-averse than the risk-loving
individuals considered by Scherer.").
129. See Cotropia, supra note 2, at 765-66. But see Rantanen & Petherbridge,
supra note 109, at 19 (arguing that, post-Therasense, applicants might be inclined to take
too many risks).
130. A credence good or service is one the quality of which the buyer has
difficulty evaluating even after she has consumed it. See Michael R. Darby & Edi Kami,
Free Competition and the Optimal Amount of Fraud, 16 J.L. & EcoN. 67, 68-69 (1973).
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would become cost-ineffective. The USPTO's proposed rule requiring applicants
to explain the relevance of information disclosed in an IDS1 31 could have this
effect, though it could have other consequences as well. In terms of Expression (7),
raising CAP could result in more cases in which E(R)D = RIP(Not-A) + R2P(A) -
CA,, - FD < 0, with the result that the applicant might prefer abandoning the
application to disclosing. On the other hand, to the extent an improved IDS would
make it easier for the examiner to focus on relevant information, the number of
erroneous grants should decrease, thus reducing the costs that invalid patents
impose on potential licensees and accused infringers. In terms of the overall
purpose of the inequitable conduct doctrine, however, requiring such disclosure
makes sense only if (as Expression (2) proposes) CApp < CExam. In terms of Figure 1
above, the effect of such a move would be to shift UApp to the left; the disparity
Figure 1 assumes between Q* and Q** would likely decrease.
Another possibility would be to raise the cost to defendants of asserting
the defense. As noted above, defendants already must plead the defense with
particularity and must prove materiality and intent by clear and convincing
evidence. 132 Some commentators nevertheless have argued that the defense is often
raised for its nuisance value and have argued that courts or Congress should
consider reforms that would target such abuses, such as more frequently awarding
prevailing plaintiffs the attorney's fees they incur in responding to the defense.
1 33
The model presented above does not directly capture the effects of the defense on
defendant behavior; but reforms that would make the defense potentially more
costly to assert presumably would reduce the frequency with which the defense is
asserted, thus lowering FND and reducing the quantity of information applicants
disclose purely for defensive purposes.
Another possible reform that, on its face, has nothing to do with the
inequitable conduct doctrine would nevertheless likely impact the doctrine
131. See Changes to Information Disclosure Statement Requirements and Other
Related Matters, 71 Fed. Reg. 38,808, 38,809 (July 10, 2006) (to be codified at 37 C.F.R. pt.
1); see also FED. TRADE COMM'N, supra note 2, ch. 5, at 12-13 (recommending greater use
of relevance statements); Cotropia, supra note 2, at 777-78 (arguing in favor of prohibiting
the submission of cumulative and nonmaterial prior art); Nolan-Stevaux, supra note 2, at
171-72 (arguing in favor of relevance statements). Alternatively, the USPTO or a court
could impose a penalty of some sort for the disclosure of nonmaterial information, though I
would worry that such a solution would aggravate the administrative costs of the current
system absent a very clear definition of materiality.
132. See supra note 28.
133. See, e.g., NAT'L RESEARCH COUNCIL, supra note 2, at 123 (arguing in favor
of fee shifting); Dolak, supra note 2, at 892 ("[I]t may make sense to implement a fee-
shifting provision in favor of patentees who prevail on the issue [of inequitable conduct], for
example, an automatic award of inequitable-conduct-related attorney fees to a plaintiff who
prevails on inequitable conduct, regardless of whether the patentee wins on infringement
and validity."); McGowan, supra note 2, at 980 (arguing for "more liberal use of fee awards
for meritless assertions of the defense"); Brown, supra note 2, at 627-28 (arguing for fee
shifting when a court awards summary judgment to the patentee on the issue of inequitable
conduct); Mack, supra note 2, at 172 (proposing fee shifting); Nolan-Stevaux, supra note 2,
at 167-69 (arguing for fee shifting when a court awards summary judgment to the patentee
on the issue of inequitable conduct).
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indirectly. The reform at issue is the adoption of a post-grant opposition process
similar to that which other nations have in place.' 3 4 The purpose of introducing
post-grant oppositions would be to provide a method, speedier and more effective
than current reexamination procedures, for interested parties to challenge
potentially invalid patents shortly after grant, before the issue is likely to arise in
litigation. 135 Assuming the reform has the intended consequence of bringing more
invalidating prior art to the attention of the USPTO, the reform would tend to
increase dE. 136 The effect would likely be to increase disclosure, because an
increase in dE increases all three variables from the left-hand side of Expression (6)
(RIP(Not-A fl B n dE fl dND), R2P(A n B nl dE f dND), and FND) and decreases the
first term on the right. (Increasing dE also increases the R3 term on the right, but as
long as this term remains at or near zero the effect will be minimal.) To the extent
the current system already induces overdisclosure, introduction of an opposition
system into U.S. law could aggravate the problem to some extent. The reform
nevertheless might be desirable if it has the intended effect of weeding out invalid
patents (and thus reducing their social costs) at a relatively early stage. Moreover,
one might speculate that reform of the inequitable conduct doctrine, coupled with
the adoption of an opposition system, would tend to cancel out any risk of
encouraging yet more overdisclosure. The fact that other countries have
oppositions and not an inequitable conduct doctrine, as such,137 suggests the
134. The various proposed Patent Reform Acts also have included provisions that
would enable third parties to submit prior art to the USPTO before the issuance of the
patent, though not to commence opposition proceedings at that time. See, e.g., S. 23, 112th
Cong., §§ 5, 7 (2011), available at http://www.govtrack.us/congress/billtext.xpd?bill=sl 12-
23; HR 1249, 112th Cong., §§ 5, 7 (2011), available at
http://www.govtrack.us/congress/bill.xpd?bill=h112-1249. Some other commentators have
suggested a relationship between inequitable conduct and third-party submissions and
oppositions. See NAT'L RESEARCH COUNCIL, supra note 2, at 123 (arguing that the doctrine
would be unnecessary in light of such reforms); Armitage, supra note 2, at 6 (arguing that
"commercially motivated competitors would likely assure that the information on which
patent validity depends would be put before the Office" if Congress enacted legislation
requiring publication of all applications at filing, permitting post-application submissions,
and permitting post-grant oppositions); Wasserman, supra note 2, at 26; Harold C. Wegner,
Inequitable Conduct and the Proper Roles of Patent Attorney and Examiner in an Era of
International Patent Harmonization, 16 AIPLA Q.J. 38, 41, 73 (1988).
135. See S. REp. No. 110-259, at 18-23 (2008); see also NAT'L RESEARCH
COUNCIL, supra note 2, at 95-103.
136. To be sure, some such prior art would have been discovered later on, in
litigation or elsewhere. But some of it might have escaped the attention of the infringement
defendant.
137. See Tatsuya Misawa, Decision Standards for Duty of Disclosure, 2004 INST.
INTELL. PROP. BULL. 136, 140. This article notes:
The basis of the U.S. system for disclosure of information is
compliance with the duty of candor. The U.S. system is a unique system
in comparison to other countries' systems. Even in the United Kingdom
which also uses common law as a base, inequitable conduct will not
lead to the invalidation of a patent or the impossibility of exercise of the
right.
Id. at 140. For example, "[i]n the U.K. Patents Act 1949, a false suggestion and
representation were reasons for revocation." Id. at 140 n.24.
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possibility that disclosure is adequate under such a combination, though, of course,
no definitive inferences can be drawn merely from possibilities. Alternatively, the
lack of an inequitable conduct doctrine in other countries may help to explain why
oppositions are an important part of foreign patent systems. Either way, the
analysis provides some reason for concern that eliminating the inequitable conduct
doctrine altogether, without adopting oppositions or other measures designed to
increase dE, might be ill-advised.
CONCLUSION
At the end of the day, the formal analysis presented above leaves open
many questions concerning the optimal contours of the doctrine of inequitable
conduct. The analysis nevertheless does suggest several practical implications:
among them that the doctrine is at best an imperfect means of inducing optimal
disclosure; that, both pre- and post-Therasense, the doctrine leaves many key
concepts without any precise definition; that the resulting uncertainties in the
operation of existing doctrine may induce risk-averse agents to overdisclose; that,
to the extent overdisclosure was or remains a pressing problem, any of a number of
reforms would reduce the doctrine's significance, with the clear adoption of a
single but-for standard of materiality probably having the greatest potential payoff;
and that the social benefits of an inequitable conduct doctrine are likely to be
greater in a system like the United States' in which opportunities for post-grant
oppositions are constrained (conversely, the benefits of an expansive inequitable
conduct doctrine may be small or negative in a system in which post-grant
oppositions are common). Future work might fruitfully explore ways to test some
of these conclusions empirically, for example, by investigating whether foreign
patent regimes suffer from a greater incidence of fraud-related harms in the
licensing and enforcement of patents. It also may be worth noting that, while the
"False suggestion" remains a ground for revocation in some countries. See, e.g.,
Ranbaxy Austl. Pty Ltd. v. Warner-Lambert Co., [2008] FCAFC 82, 135-40 (Austl.). In
addition, some courts in Canada have held that misrepresentations made in response to a
patent examiner's request for information violates a duty of candor and can result in a
finding of patent abandonment. See BRADLEY LIMPERT, TECHNOLOGY CONTRACTING: LAW,
PRECEDENTS AND COMMENTARY §§ 5.3(d)(iv), (e)(i) (2005) (reviewing Canadian case law).
Cf 37 C.F.R. § 1.105(a)(1) (2009) (authorizing examiners to "require the submission, from
individuals identified under § 1.56(c), or any assignee, of such information as may be
reasonably necessary to properly examine or treat the matter," and threatening a finding of
abandonment in the event of a failure to reply); European Patent Convention art. 124(l)-(2)
(2000), available at http://www.epo.org/law-practice/legal-texts/html/epc/2010/e/
ar124.html#conv.f134-note (authorizing the European Patent Office to "invite the applicant
to provide information on prior art taken into consideration in national or regional patent
proceedings and concerning an invention to which the European patent application relates,"
and providing that in the event of a failure "to reply in due time ... the European patent
application shall be deemed to be withdrawn"). As in Japan, however, there appears to be
no close counterpart under European law to the United States' inequitable conduct doctrine.
See Jan Krauss & Toshiko Takenaka, Neuere US-Entscheidungen betreffend ,,Inequitable
Conduct" und ihre Effekte auf internationale Patent-Anmeldeverfahren, 2010
MITrEILUNGEN DER DEUTSCHEN PATENTANWALTE [MITr. HEFT] 569, 570-71 (Ger.).
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optimal amount of fraud in the absence of error and enforcement costs may be
zero, 138 in the presence of such costs attempts to reduce false negatives to zero not
only will be costly to enforce but may also dilute the value of truthful information
to some degree. 139 As courts and Congress struggle to develop a better framework,
they would do well to consider the trade-offs and imperfections inherent in any
system designed to reduce the incidence of fraud.
138. See Ackerman v. Schwartz, 947 F.2d 841, 847 (7th Cir. 1991).
139. See Cotropia, supra note 2, at 770-73; see also Richard Craswell,
Interpreting Deceptive Advertising, 65 B.U. L. REv. 657, 688-92 (1985) (arguing that
overregulation of false advertising can be counterproductive to the extent it chills
advertisers from making truthful statements as well).
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